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Proton radiotherapy is becoming popular as an effective modality to treat cancer. 
However the advantages of the proton radiotherapy could be offset due to the effect 
of secondary neutrons. Secondary neutrons are an undesired byproduct in proton 
radiotherapy. It is important to quantify the dose equivalent due to secondary 
neutrons since they could lead to secondary cancer later in the patient’s life. In this 
study, our aim was to investigate the off-axis dose equivalent due to secondary 
neutrons from a uniform scanning proton radiotherapy system at the ProCure 
Proton Therapy Center, Oklahoma City, OK. Both experiments and simulations were 
carried out for the purpose of this study. CR-39 plastic nuclear track detectors were 
used to measure dose equivalent inside a phantom and in air at various depths and 
angles with respect to the primary beam axis for four different experimental 
configurations. Three different proton beam energies, 78 MeV, 162 MeV and 
226 MeV, all using a 4 cm modulation width, a 5 cm diameter brass aperture, and a 
small snout located 38 cm from isocenter were used for the experiments. The Monte 
Carlo radiation transport code FLUKA was used to simulate the experiments for a 
simplified snout configuration. The measured ratio of secondary neutron dose 
equivalent to therapeutic primary proton dose (Hn/Dp) ranged from 0.3 mSv/Gy to 
50 mSv/Gy. Both experiment and simulation showed a similar decreasing trend in 
dose equivalent with distance from beam isocenter and the magnitude varied by a 
factor of about 4 in most of the locations. An overall higher Hn/Dp in air than inside 
the phantom was observed and this suggests that the production of secondary 
neutrons in the beam delivery device is significantly higher than inside the body. 
Comparison of Hn/Dp with other studies suggests that the neutron exposure to 
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In radiation therapy, the purpose is to deliver a greater dose of ionizing radiation to 
the cancerous tumor, sufficient to kill the tumor, while delivering a minimal dose to 
the surrounding healthy tissue. Protons have been used in radiation therapy for 
several decades and are continually gaining in popularity. This is primarily because 
energetic protons have finite range and deposit most of their energy near the end of 
their range, known as Bragg peak. In 1945, Robert Wilson first suggested that the 
property of Bragg peak of energetic protons might be useful in medical use. This is 
because, by modulating the energy (range) of the beam, the Bragg peak can be made 
to coincide with the location of the tumor in the patient body. This will allow 
protons to deposit most of their energy to the tumor and a minimum energy to the 
healthy tissues surrounding the tumor.  
 
Proton radiotherapy has nearly about 50 years of history. But it has been very slow 
of becoming a routine modality mostly due to the expense of an accelerator to 
achieve protons of energy from 50 MeV to 250 MeV required for the treatment. 
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However, in the last ten years, there has been a rapid growth of proton treatment 
facilities around the world due to the precise dose delivery that a proton beam can 
offer. Currently, there are 38 proton facilities operating around the world and 34 
more is under consideration (PTCOG, 2013). This growing number suggests that 
proton radiotherapy is becoming increasingly important as an effective form of 
radiotherapy in the years to come.  
 
The primary proton beam, used in proton radiotherapy, is generally too narrow to 
cover a tumor of practical size. For this reason, the beam needs to spread over the 
treatment volume. The spreading of a beam is done in beam delivery device either 
by inserting scattering material along the beam path commonly known as passive 
scattering system, or by using sweeping magnets to scan the beam onto the tumor 
known as active scanning system. When the beam is shaped, primary protons will 
undergo nuclear interactions with different beam shaping components in the beam 
delivery device, resulting the production of secondary neutrons, known as external 
neutrons (Perez-Andujar et al., 2009, Polf et al., 2005, Polf and Newhauser, 2005, 
Hecksel et al., 2010, Jiang et al., 2005, Zheng et al., 2007b, Zheng et al., 2008, Zheng 
et al., 2007a, Moyers et al., 2008, Binns and Hough, 1997). Neutrons can also be 
created inside the body due to the nuclear interaction of proton with tissue mass, 
commonly known as internal neutrons.  
 
Neutrons have long been known to capable of doing greater biological damage than 
similar dose of x-rays, electrons or protons. Partly, this is due to the fact that 
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neutrons do not interact through Coulomb barrier; instead, the interaction occurs 
through nuclear interaction processes. As a result, energy tends to be transferred 
through light nuclei due to elastic and inelastic nuclear interaction, causing greater 
damages to the cell. This makes neutrons more biologically damaging, i.e. higher 
relative biological effectiveness (RBE) compared to other forms of radiation such as 
x-rays, and protons. Because of the higher RBE, neutrons may lead a secondary 
cancer later in the patient’s lifetime. Due to the risk of secondary cancer, the 
secondary neutrons produced in proton treatment facility should be assessed, 
monitored, and minimized as much as possible.  
 
The measurement of dose and dose equivalent due to neutrons is not 
straightforward. This is because the interaction probability (cross section) of 
neutrons with detecting material (e.g. gas) used in common radiation detector (e.g. 
ionization chamber) is negligible. In addition, the signal due to neutrons is swamped 
by the primary radiation in such detectors. Due to this, special methods are needed 
to employ for the detection of neutrons of variable energies. Common types of 
neutron detectors used in neutron dosimetry include, REM meter, Bonner sphere, 
bubble detector, etc., where a fluence to dose equivalent conversion coefficients is 
used to measure the neutron dose equivalent. The conversion coefficients used in 
these detectors are, in general, determined based on the Monte Carlo method, 
allowing a greater uncertainty in the measured result.  
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An alternative detector in neutron dosimetry is CR-39 plastic nuclear track detector 
(PNTD). CR-39 PNTD is a thin plastic polymer and the advantages of CR-39 PNTD 
include: a) CR-39 PNTD is insensitive to primary protons but has tissue like 
sensitivity to the neutrons, b) dose and dose equivalent can be measured directly 
from the LET information of the incident particles, and c) unlike other detectors it is 
thin and can be placed anywhere inside the phantom to measure organ equivalent 
dose. For all these reasons, this study uses CR-39 PNTD for the measurement of 
dose equivalent from secondary neutrons.    
 
In this work, our aim is to study the off-axis secondary neutrons created from a 
uniform scanning proton beam used at ProCure Proton Therapy Center, OK. The 
uniform scanning beam delivery system is a very recent development and not many 
treatment centers have this mode of beam delivery system available. Also, the 
literature available for the secondary neutrons due to uniform scanning is scarce. In 
addition, no treatment planning technique in proton radiotherapy to date accounts 
the possible neutron exposure. The objective of this work is to quantify the dose 
equivalent due to secondary neutrons produced in a uniform scanning system inside 
the phantom and in air at different angles and locations relative to isocenter of the 
beam for different proton energies with a typical treatment set up. The study was 
carried out by means of experiment and simulation using a simplified version of 
uniform scanning systems (See Section 2.6.2.2) currently in use at ProCure Proton 
Therapy Center, Oklahoma City, OK. The focus of this study is to help with the 
followings:  
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a) quantitative study of dose equivalent due to secondary neutrons for a 
common proton radiotherapy treatment facility using uniform 
scanning beam delivery system  
b) if uniform scanning beam delivery system serves better over passive 
scattering system in neutron production 
c) if there is a need to improving beam shaping components for better 
shielding of neutrons used in uniform scanning system   
 
 Organization of this work  1.1
 
This work presents general radiation therapy, the rationale for proton radiotherapy, 
underlying principle of proton radiotherapy, and the current status of proton 
radiotherapy in Chapter Two. Different types of beam shaping devices including 
active scanning and passive scattering devices are also discussed here. The neutrons 
environment at a common proton radiotherapy treatment facility and the basic 
mechanism responsible for the production of secondary neutrons is presented in 
Chapter Three. Chapter Four discusses on the fundamental dosimetric quantities 
required for the calculation of absorbed dose and dose equivalent. The method of 
fluence to dose equivalent conversion in FLUKA is also discussed in Chapter Four. 
The detail about CR-39 plastic nuclear track detector, experimental design and 
simulation approach is presented in Chapter Five. Chapter Five also discusses on the 
design of experiment and numerical configurations that has been employed in this 
study and the importance of such approaches in determining neutrons dose 
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equivalent in proton radiotherapy. Detector read-out process and the method used 
to analyze the experimental and simulated data are presented in Chapter Six. 
Results from both experiment and simulation from this study is presented in 
Chapter Seven. Finally, Chapter Eight compares results from this study with 
published data for similar passive scattering and uniform scanning beam delivery 
systems. A summary of this study and related future work is also mentioned in 
Chapter Eight. 
 







This chapter describes radiation therapy and compares different modes of 
radiotherapy. The history of proton radiotherapy, current status, and underlying 
principle of proton radiotherapy are presented. The beam delivery system in proton 
radiotherapy plays an important role in shaping the beam to the contours of the 
tumor. The design of the beam delivery system also plays a major role in the number 
of secondary neutrons produced by the proton radiotherapy beam.  A number of 
different types of beam delivery system have been developed for use in proton 
radiotherapy and three major types will be described in detail, especially with 
regard to the production of secondary neutrons.  
 
 General Radiotherapy  2.1
 
Radiation therapy (or radiotherapy) refers the use of ionizing radiation to treat 
cancer by killing the malignant cells that make up the tumor. The objective of 
radiotherapy is to deliver a high dose of ionizing radiation to the tumor volume 
while at the same time minimizing the dose of ionizing radiation delivered to the 
healthy tissue surrounding the tumor. 
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Table 2.1: The rate of Radiotherapy used by cancer patients according to cancer type (Joiner 
and Kogel, 2009).  














Melanoma 11 23 2.5 
Prostate 12 60 7.2 
Gynaecological 5 35 1.8 
Colon 9 14 1.3 
Rectum 5 61 3.1 
Head and neck 4 78 3.1 
Gall bladder 1 13 0.1 
Liver 1 0 0.0 
Oesophageal 1 80 0.8 
Stomach 2 68 1.4 
Pancreas 2 57 1.1 
Lymphoma 4 65 2.6 
Leukaemia 3 4 0.1 
Myeloma 1 38 0.4 
Central nervous 
system 2 92 1.8 
Renal 3 27 0.8 
Bladder 3 58 1.7 
Testis 1 49 0.5 
Thyroid 1 10 0.1 
Unknown primary 4 61 
13 83 10.8 
Lung 10 76 7.6 
Melanoma 11 23 2.5 
Prostate 12 60 7.2 
Gynecological 5 35 1.8 
Colon 9 14 1.3 
Rectum 5 61 3.1 
Head and Neck 4 78 3.1 
Gall Bladder 1 13 0.1 
Liver 1 0 0.0 
Esophageal 1 80 0.8 
Stomach 2 68 1.4 
Pancreas 2 57 1.1 
Lymphoma 4 65 2.6 
Leukemia 3 4 0.1 
Myeloma 1 38 0.4 
Cancer nervous system 2 92 1.8 
Renal 3 27 0.8 
Bladder 3 58 1.7 
Testis 1 49 0.5 
Thyroid 1 10 0.1 
Unknown primary 4 61 2.4 
Other 2 50 1.0 
Total 100  52.3 
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Today, radiotherapy is one of the most effective treatments for cancer. In a study 
summarized in Table 2.1, Tobias and Delaney et. al. (Tobias, 1996, Delaney et al., 
2005), showed that more than half of all cancer patients (52.3%) receive 
radiotherapy at some point in their treatment. This table shows the percent of 
patients receiving radiotherapy as a principal form of treatment as well as the 
percent of patients of all types of cancers receives radiotherapy at some stage of 
treatment. 
 
In the early stage of cancer, especially when the cancer is confined to a single tumor 
and has not metastasized (spread to the other organs), surgery is the preferred 
treatment. Radiotherapy is an alternative to surgery and an effective form of 
treatment for long term control of tumors in the lung, cervix, bladder, prostate, head 
and neck, skin, and other organs.  Chemotherapy (where strong chemical agents are 
used to control the malignant cancerous cells) is the third most important form of 
cancer treatment, is also popular (Joiner and Kogel, 2009). However, the success 
rate for treating cancers using chemotherapy alone is low. For local treatment of 
most types of tumors, a combination of radiotherapy and surgery have a success 
rate of about 40% (Souhami and Tobias, 1986, DeVita et al., 1979).  Radiotherapy as 
the principal form of treatment has a success rate of about 15% for all types of 
cancers, whereas the success rate due to chemotherapy alone is about 2% (Joiner 
and Kogel, 2009). That study estimated that the patient cure rate was around seven 
times higher in radiotherapy compared to chemotherapy. However, it is important 
to note that depending on the stage of the cancer, radiotherapy is sometimes 
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combined with chemotherapy or surgery for treating cancer patients. Based on 
patient’s age, tumor location, stage of the tumor development, and the general 
health of the patient, the final choice of the treatment modality is made. 
 
In radiation therapy, the tumor is given a prescribed amount dose using ionizing 
radiation. Exposure of biological cells to ionizing radiation can lead to damage to the 
cell’s DNA. In general, the more frequently a cell undergoes mitosis (reproduction) 
the more sensitive it is to radiation damage, i.e. the less likely the cell can correctly 
repair damage due to radiation exposure. Consequently, cancer cells less likely to 
repair the damage caused by radiation compared to healthy cells. 
  
Damage to DNA by ionizing radiation can take one of the two forms: direct damage 
and indirect damage. An illustration of direct or indirect interaction is shown in 
Figure 2.1. Direct damage occurs when the energetic charged particle or photon 
interacts directly with one or more electrons belonging to the DNA, causing a break 
in the DNA strand. Indirect reaction, on the other hand, damages cells via free 
radical. A free radical is highly reactive molecule, atom or ion that has an unpaired 
orbital electron in the outer shell and is formed when ionizing radiation interacts 
with small molecules such as water molecules. Such an interaction can be expressed 
as: 
 
                 
      
 




Figure 2.1: A schematic representation of direct and indirect action. Picture was adapted 
from (Hall and Giaccia, 2006).  
 
The free ion radical (   
 ) interact again with another water molecule and produce 
an hydroxyl radicals (   ):  
   
         
       
 
Hydroxyl free radicals (   ) are extremely reactive and cause harmful chemical 
reactions within the cell including reacting with a DNA molecule leading to a strand 
break. It has been estimated that about two thirds of all damage done to cells by 
exposure to x-rays can be attributed due to hydroxyl free radicals in indirect 
interactions (Saha, 2006). Energetic protons and heavy ions mostly damage the cell 
     
12 
 
via direct reaction, whereas photons and x-rays primarily damage the cell via 
indirect interactions.     
 
 Different forms of Radiotherapy 2.1.1
  
Depending on the source of radiation, radiation therapy can take two forms: a) 
external beam radiation therapy (EBRT or XBRT), and b) internal radiotherapy. In 
external beam radiation therapy, an external source of radiation is placed outside 
the body to treat cancerous tumors. X-rays and electrons are the most widely used 
form of radiation in external beam radiation therapy. Superficial tumors such as 
those on or near the skin are often treated using electrons or low energy (kilo-
voltage) x-rays, whereas, megavoltage x-rays are used for deep seated tumors such 
as tumors in the prostate, lungs, etc. The use of energetic protons and heavy ions 
also fall in the category of external beam radiotherapy. External beam radiation 
therapy is further classified as conventional and unconventional radiotherapy. 
Conventional radiotherapy includes x-ray and electron beam radiotherapy, while 
unconventional radiotherapy includes proton and heavy ion beam radiotherapy.  
 
Internal radiation therapy, on the other hand, uses radioisotope as radiation source 
and dose is delivered by placing the source inside or on the treatment volume (Patel 
and Arthur, 2006). This form of treatment uses both sealed and unsealed 
radioactive source (NCI, 2013). The use of sealed radioactive sources in and around 
the tumor is generally known as Brachytherapy. In this method, the placement of 
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the sources could be either, inside a cavity (intracavity), inside a tumor 
(interstitialy) or attached to the surface (Khan, 2003). The most common types of 
radioactive sources used in brachytherapy are 98Au, 125I, 192Ir, and 113Pd. By placing 
radioisotopes sources or seeds within and in close proximity to the tumor volume, a 
greater dose can be delivered locally to the tumor while the dose falls off rapidly 
with distance from the source in the adjacent healthy tissues. Because of this rapid 
dose fall off, brachytherapy is popular in the treatment of prostate, cervical, breast, 
and skin cancers. In addition, brachytherapy is sometimes used in conjunction with 
external radiation therapy to boost the dose directly deliver to the tumor.  
 
Radiotherapy with unsealed sources sometimes also referred as brachytherapy uses 
soluble forms of radioactive sources such as 131I. This isotope is administered either 
via injection or ingestion. The use of unsealed sources in radiation therapy is 
effective only for some types of thyroid cancer, since thyroid cells naturally absorb 
both radioactive and stable iodine (NCI, 2013). However, depending on the tumor 
stage, a combination of external and internal beam therapy is commonly prescribed 
in treatment for thyroid cancer. 
     
 Basics of Proton Therapy 2.2
 
In proton radiotherapy, the energetic protons interact with matter through three 
different processes (Goitein, 2008): a) coulomb interactions with atomic electrons, 
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b) coulomb interactions with atomic nuclei, and c) nuclear interactions with atomic 
nuclei. Coulomb interactions with atomic electrons occur when high energy 
positively charged protons interact with the negatively charged orbital electrons. 
This process transfers enough kinetic energy to the electrons to cause excitation and 
ionization of the atoms. The ionization process takes place when the interacting 
protons transfer sufficient energy and knock out one or more electrons from the 
target atom. Most of the ejected electrons in ionization process contain small 
amounts of energy and are stopped in the immediate vicinity of the trajectory of the 
primary proton. Some of these ejected electrons may receive sufficient energy to 
travel macroscopic distances inside the matter. These high energy electrons are 
commonly referred as δ-rays and they can cause further excitation and ionization in 
the region surrounding the initial interaction. The deflection of primary protons in 
this process is negligible since protons are much heavier than electrons. 
 
Protons also interact with the coulomb fields of atomic nuclei as they penetrate 
through matter. Since both protons and nuclei are positively charged, repulsion 
takes place between incoming protons and atomic nuclei. This causes the protons to 
scatter since nuclei are of equal or greater mass than the incident protons. However, 
the net statistical deflection is typically very small after many of such scattering 
events (Goitein, 2008).  
 
Nuclear interactions with atomic nuclei are another process which occurs via the 
strong nuclear force. There are two types of nuclear collision: a) elastic collisions, 
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and b) non-elastic collisions. In elastic collisions, the incident proton transfers a 
significant fraction of its kinetic energy to the target nucleus, while the nucleus 
remains intact and the incident proton is deflected by several degrees. An example 
of an elastic collision of proton with an oxygen nucleus can be written as: 
    
       
    
In a non-elastic collision, the interaction of an incident proton with a target nucleus 
may cause the nucleus to break apart and as a result, fragments of the target nucleus 
may emerge considerable kinetic energy. In this process, incident protons lose a 
significant kinetic energy and can be deflected by several degrees. An example of a 
non-elastic collision of proton with an oxygen atom can be written as: 
    
         
    
   
Table 2.2 shows the results due to non-elastic collisions of 150 MeV protons on 16O 
nuclei (Seltzer, 1993).  
 
Table 2.2: Energy taken up by various particles as a result of 150 MeV protons 
incident on 16O nucleus (Seltzer, 1993).  
Particle Fraction of energy (%) 
Protons 57 
Neutrons 20 




Recoil fragments 1.6 
 




Among different processes, the primary mechanism for energy loss by protons as 
they pass through the matter is the Coulomb interaction with the atomic electrons 
of the stopping medium. Incident protons in this process experience a gradual loss 
of energy as they penetrate through matter. The loss of energy of primary protons is 
not same at all depths in the medium. The loss of energy due to Coulomb 





   
 
    
    




 is the energy lost by the incident charged particle proton per unit path 
length, ne represents the electron density of the target, e represents electron charge, 
 represents the permittivity of free space, m is the rest mass of the electron, L 
represents a collection of logarithmic factors and correction factors. Bethe-Bloch 
formula assumes that the target electrons are free. This assumption is valid because 
the binding energy of electrons is much lower than the energy of the incident 




    (
    
 









  2.2 
 
The standard relativistic corrections,           ⁄        ⁄  are important if the 
projectile in the interaction is moving at a significant fraction of the speed of light. If 
the velocity of the projectile is small compared to the speed of light, Equation (2.2) 
simplifies to L         ⁄    where   is the velocity of the incident charged particle 
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and I is the mean ionization potential. The term,   ⁄ , in Equation (2.2) represents 
the density effect correction (Sternheimer and Peierls, 1971).  
 
From Equation 2.1, the energy loss of an incident proton is roughly proportional to 
the inverse square of its velocity. For this reason, when the velocity of a proton 
decreases, the energy lost to the stopping medium increases. At the end of the 
proton range, when the velocity reaches a minimum, the energy loss reaches a 
maximum causing a peak at the end of its range. This is known as the Bragg peak 
and this energy loss profile of charged particle in the stopping medium is known as 
Bragg curve. An example of a Bragg curve for a 200 MeV proton in water is shown in 
Figure 2.2 (Jones and Schreuder, 2001).  
 
 
Figure 2.2: A Bragg curve for 200 MeV proton beam in water (Jones and Schreuder, 2001). 
The Bragg peak is seen at a depth of about 23 cm.  
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The width of the Bragg peak is caused by the statistical variations in the ionization 
processes known as range straggling. Range straggling refers to the fact that not all 
the protons have the same range as there are statistical differences in the ionization 
processes, causing the end point of the protons to spread out. In addition, the energy 
of the incident proton beam is never completely monoenergetic and this also 
contributes in spreading out Bragg peak. 
 
 Benefits of proton radiotherapy  2.3
 
In conventional external beam radiotherapy, dose delivered to the patients falls-off 
exponentially with depth in the patient’s body. This leads to the healthy tissue 
adjacent to the tumor volume receiving significant dose. This problem of minimizing 
dose to healthy tissue is better handled using proton beams. Protons are relatively 
heavier and have finite range in matter. The relatively heavy mass allows protons to 
scatter less as it travel through the matter and the finite range stops the beam at a 
certain depth inside the tissue. This combination allows the proton beam to deliver 
maximum energy at the end of its range (i.e. at Bragg peak) and keep focused as it 
propagates through matter.   
 



















Figure 2.3: Range of proton beam in water. Data taken from NIST website (NIST, 2012). 
 
An example of the range of proton beam for therapeutic energy (up to 300 MeV) in 
water is shown in Figure 2.3 (NIST). As shown in the figure, a given kinetic energy of 
a proton corresponds to finite range in water or tissue. This provides a distinct 
clinical advantage. On the other hand, x-rays do not stop after a finite range but 
attenuate exponentially with depth in tissue. Because of their inherent properties, x-
rays deliver maximum dose near the entrance and a considerably higher dose to the 
healthy tissue near the treatment volume. Protons, unlike x-rays, deliver a higher 
dose to the tumor using the Bragg peak property and minimum dose to the adjacent 
healthy tissue.  
 
     
20 
 
Figure 2.4 shows an example of dose deposition in tissue as a function of depth for 
three different modes of treatment: x-rays (20MV), electrons (4MeV), and protons 
(150 MeV). As can be seen from this figure, protons deliver most of their dose at the 
end of their range while x-rays start with a dose build up and then falls off 
exponentially. Electron beams, on the other hand, show a greater dose fall off but 
this clinical advantage is limited to lower energy only. As the energy of the electron 
beam increase, the beam becomes contaminated with x-rays and also electron 
scatters to a great extent as they travel through the tissue. Clinically, this restricts 
the use of electron beams to treatment of shallow tumors.   
 
 
Figure 2.4: Comparison of depth dose curve for x-rays (20MV), electrons (4MeV), and 
protons (150 MeV) beams. Picture taken from (Wikimedia, 2013). 
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Dose distributions from x-rays and protons in a patient with medulloblastoma are 
shown in the Figure 2.5 (Terezakis et al., 2011). In this study, the dose distribution 
due to x-rays and proton is shown for craniospinal irradiation, i.e. spinal column is 
irradiated to prevent the spread of malignant cells via the spinal fluids. In the image, 
different colors represent dose distribution with red corresponding to the highest 
dose and blue corresponding to the lowest dose. The top figure (A) shows the dose 
distribution due to an x-ray beam and the bottom figure (B) shows the dose due to 
proton beam. As can be seen from this figure, for x-rays, healthy tissue beyond the 
spinal column receive significant dose, whereas, proton beam deposits negligible 
dose beyond the spinal column. Clinically, the advantage of precise deposition of 
dose has placed proton radiotherapy as a superior modality compared to x-rays and 
electron radiotherapy (Dowdell, 2011). For this reason, proton radiotherapy has 
been proving effective in critical cases such as tumors in pediatric patients 
(Dowdell), tumors in head and neck (Steneker et al., 2006, Dowdell, 2011), and 
ocular tumors (Dendale et al., 2006).  
          





Figure 2.5: A comparison of dose distribution in a patient due to photon and proton 
beam for medulloblastoma (Terezakis et al., 2011).   
 
 History of proton radiotherapy and present status  2.4
 
Among different modes of radiation therapy, the use of proton beam has recently 
started gaining in popularity. In 1946, Robert Wilson first suggested that the beams 
of energetic protons can be employed in the treatment of cancer  (Wilson, 1946). 
The key points that he made at that time were: a) the relatively larger mass of 
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proton compared to x-rays and electrons would cause less scattering, better 
confining the radiation to the tumor volume, and b) the greater energy deposition of 
protons at the end of their range would allow highly localized irradiation that would 
spare nearby healthy tissues. Following Robert Wilson’s suggestion, different 
groups started to investigate the biological effects of energetic charged particles. 
The first studies were conducted by Tobias et. al. (ICRU, 2007) in 1952 at the 
University of California Berkley. This group reported the effect of high whole body 
doses that would kill fifty percent of tested cell population in the laboratory mice. 
During that time, few other groups were involved in the investigation in finding the 
biological effects on experimental animals from exposure to energy protons.  
 
The first use of proton beams on a human patient was also conducted at the 
University of California, Berkley. This work was designed to suppress the hormone 
production by the pituitary gland to control breast cancers. Since a high proportion 
of breast cancers are hormone dependent. For this purpose, pituitary glands of 
different experimental animals were irradiated with energetic protons. Following 
irradiation, a substantial reduction in the pituitary gland was observed. With this 
discovery, the Berkley group decided to conduct a phase-I clinical trial on human 
patients with breast carcinoma (ICRU, 2007).  
 
In 1954, eight years after Robert Wilson’s original suggestion, first patient was 
treated using protons  at the University of California, Berkley (Tobias et al., 1958), 
Around 26 patients were treated in that study and several patients experienced 
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great clinical response. In 1957, the Berkley group expanded the study to investigate 
the clinical response of tumors with other heavy ion beams including helium, carbon 
and neon. During this period treatment was limited to only a few types of tumor. In 
addition, the treatment of deep seated tumors was not possible as the accelerator 
had not been designed for medical use and the energy of the beam was not high 
enough to penetrate to the greater depths within the patient’s body.  
 
In 1961, proton therapy began on a regular basis in USA using the 160 MeV 
synchrocyclotron at the Harvard University cyclotron laboratory. Patients with 
pituitary adenomas, intracranial tumors, and arteriovenous malformations (AVM) 
were treated using multiple narrow beams (ICRU, 2007). Following the irradiation, 
significant clinical responses were observed for the patients with pituitary 
adenomas and AVMs. Treatment with energetic protons of different sites of the body 
soon followed. At the same time, researchers started to consider the efficacy of a 
fractionated dose instead of one large dose. In 1973, Suit et. al. (ICRU, 2007) 
conducted such an study to investigate the efficacy of fractionated doses to 
malignant tumors. The favorable outcomes of their study soon led to treatment by 
the team and subsequently applied fractionated dose to several other types of 
tumors.  
 
Outside of USA, in 1957 University of Uppsala, Sweden started treating patient using 
a 185 MeV proton beam and fractionated doses. Significant positive results were 
seen in patients with tumors of the uterus, cervix, nasopharynx, and head and neck. 
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Proton therapy started in Japan in1979, in Russia in 1967, in South Africa in 1993 
(ICRU, 2007).  During the period from 1950 to 1970, cancer treatment using proton 
beam was mostly carried out using accelerators built for physics research and this 
limited the treatment to only clinical cases. In the late 1970s, the availability of 
computers and advanced imaging technique made proton therapy more viable. The 
first purpose built accelerator for proton radiotherapy was installed in 1990  at 
Loma Linda University Medical Center in California (Slater, 1991).  
 
Currently (up to March, 2013), there are 38 proton facilities operating around the 
world and 34 more are under consideration (PTCOG, 2013). Table 2.3 provides a full 
list of proton therapy currently in operation including the year of first treatment 
and total number of patient treated through March 2013. As of March 2013, more 
than 78,000 patients have been treated using proton radiotherapy. Also, the number 
of proton therapy facilities that have opened in the recent years clearly shows that 
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Table 2.3: List of proton treatment centers currently in operation. Maximum proton energy, 
the year of first treatment, and total number of patient treated in each facility up to March 
2013 is listed (PTCOG, 2013).    
 
 






ITEP, Moscow Russia 250 1969 4246 
St. Petersburg Russia 1000 1975 1386 
PSI, Villigen Switzerland 250 1996 1409 
Dubna Russia 200 1999 922 
Uppsala Sweden 200 1989 1267 
Clatterbridge England 62 1989 2297 
Loma Linda 
 
CA, USA 250 1990 16884 
Nice France 65 1991 4692 
Osray France 230 1991 5949 
NRF ithemba Lab South Africa 200 1993 521 
IU Health PTC, Bloomington IN, USA 200 2004 1688 
UCSF/UC Davis CA, USA 60 1994 1515 
TRIUMF, Vancouver Canada 72 1995 170 
HMI, Berlin Germany 72 1998 2084 
NCC, Kashiwa Japan 235 1998 1226 
HIBMC, Hyogo Japan 230 2001 3198 
PMRC(2), Tsukuba Japan 250 2001 2516 
NPTC, MGH Boston MA,USA 235 2001 6550 
INFN-LNS, Catania Italy 60 2002 293 
SCC, Shizuoka Cancer center Japan 235 2003 1365 
STPTC, Koriyama-City Japan 235 2008 1812 
WPTC, Zibo China 230 2004 1078 
MD Anderson Cancer Center TX, USA 250 2006 3909 
UFPTI, Jacksonville FL, USA 230 2006 4272 
NCC, IIsan South Korea 230 2007 1041 
RPTC, Munich Germany 250 2009 1377 
ProCure PTC, Oklahoma city OK, USA 230 2009 1045 
HIT, Heidelberg Germany 250 2009 252 
UPenn, Philadelphia PA, USA 230 2010 1100 
CDH PC, Warrenvile IL, USA 230 2010 840 
HUPTI, Hampton VA, USA 230 2010 489 
IFJPAN, Krakow Poland 60 2011 15 
Mediopolis MRI, Ibusuki Japan 250 2011 490 
CNAO, Pavia Italy 250 2011 58 
ProCure PTC, Somerset NJ, USA 230 2012 137 
PTC Czech rso Prague Czech Republic 230 2012 1 
SCCA, ProCure PTC, Seatle WA, USA 230 2013 1 
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 Spread out Bragg peak (SOBP) 2.5
 
In proton radiotherapy, the tumor volume is placed inside the Bragg peak region to 
assure maximum dose deposition. But, usually the width of the Bragg-peak of a 
proton beam is not wide enough to completely cover a tumor volume. The 
enlargement of Bragg peak is therefore required to cover a practical size of a tumor. 
The uniform enlargement of the Bragg peak region is called the spread out Bragg 
peak (SOBP). In practice, several Bragg peaks are combined together to achieve a 
desired SOBP for the uniform dose delivery at the treatment site. During treatment, 
this is usually done by running the proton beam either through an appropriate 
range modulator or ridge filter (Chu et al., 1993).  
 
Figure 2.6: A common range modulator wheel used in proton radiotherapy. Picture taken 
from (Schlegel et al., 2006). 
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A range modulator consists of an absorber of variable thickness on a circular 
rotating disk as shown in Figure 2.6. The modulator wheel usually rotates about 
10 Hz where the combination of discrete absorber thicknesses produces a temporal 
variation in beam energy (Koehler et al., 1977). The absorber is made of a 
combination of low-Z (Lexan or polycarbonate) and high-Z (lead) material (Schlegel 
et al., 2006). The low-Z material slows down the beam with little scattering while 
the high-Z material adjusts the scattering at each depth. Each absorber thickness 
corresponds to an individual Bragg peak and each Bragg peak is assigned with an 
individual weighting factor. A weighted sum to the series of individual Bragg peaks 
is done to produce the desired SOBP (Schlegel et al., 2006).  
 
 
Figure 2.7: An example of basic ridge filter (Akagi et al., 2003). 
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A ridge filter is a typically stationary device. An example of typical ridge filter is the 
bar ridge filter shown in  
Figure 2.7. A bar ridge filter uses about 30-50 bars where aluminum is used as the 
bar material because aluminum reduces scattering compare to other metals. The 
working principle of ridge filter is similar to the range modulator wheel except that 
it is stationary and it usually does not use any high Z material. In a ridge filter, the 
use of low Z metal allows a reduction in scattering that eventually helps to reduce 
the modulator effects in the final dose distribution in the patient. However, 
depending on the beam delivery technique, both range modulator and ridge filter 
have their place in the treatment.  
 
Multiple absorbers in the range modulator or various bars in the ridge filter forms 
the required SOBP. An example of an SOBP for 200 MeV (maximum energy) proton 
beam using a range modulator is shown in Figure 2.8. As can be seen from the 
figure, each absorber thickness corresponds to a particular depth and the increasing 
depth of the absorber leads to a decreasing depth of the Bragg peak. Since each 
individual Bragg peak is assigned with a particular weight, the desired SOBP is 
produced by performing a weighted average of all the Bragg peaks.   
 




Figure 2.8: Illustration of the SOBP production using a range modulator for the maximum 
200 MeV proton energy (ICRU, 2007). 
 
 Beam delivery techniques 2.6
 
Primary proton beams that are extracted from an accelerator are nearly 
monoenergetic and possess small lateral dimensions. For the practical use, the beam 
must to conform to the dimensions of the tumor, i.e. the beam must be modified 
both laterally and longitudinally. The modification of the beam is done by a beam 
delivery system in a treatment facility. Currently, there are two types of beam 
delivery systems available: passive scattering and active scanning. In general, 
passive scattering employs scattering material in the beam path for scattering, while 
active scanning employs dynamic scanning approach to irradiate the tumor volume. 
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Although passive scattering system is more common than active scanning system, 
active scanning is considered to have the following advantages over passive 
scattering system (Albertini, 2011): a) may not require any beam shaping 
components like  range modulator, patient specific aperture, range compensator, 
etc. to achieve dose conformity, thereby reducing secondary radiation exposure, b) 
greater efficiency, i.e. the number of protons required to achieve a total dose in a 
given volume is much less in active scanning than passive scattering, so healthy 
tissue receives less dose, and c) inherently flexible in clinical use.  
 
 Passive scattering technique 2.6.1
 
Most of the treatment facilities currently in operation use the passive scattering 
method (Zheng et al., 2007a). This method may use a single scattering material or 
double scattering materials to scatter the beam. In the single scattering approach, a 
single piece of high-Z material (e.g. lead) is used for the lateral spreading of the  
beam and in double scattering technique, a second scatterer is placed further 
downstream to spread the central part of the beam as shown in Figure 2.9. The 
second scatterer typically uses a combination of low and high-Z materials. Because 
of the scattering process, the single scattering method can keep only 10% of the 
beam within the central uniform region. This makes the single scattering method 
efficient only for small treatment sites. The double scattering method, on the other 
hand, is efficient for larger treatment fields, where up to 45% of the beam remains 
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within the central region (Gottschalk, 2004). Depending on the required treatment 
field, both single and double scattering methods are currently in use.  
 
 
Figure 2.9: Schematic diagram of passive scattering system for proton radiotherapy.   
 
As shown in Figure 2.9, when the beam enters the beam delivery system, it passes 
through a series of beam shaping components. The beam starts trough a first 
scatterer, then continues through the range modulator wheel, a second scatterer, 
ionization chambers and finally passes through a snout that contains a patient 
aperture and a range compensator. The first and second scatterers spread the beam 
laterally, while the range modulator spreads the beam longitudinally. The 
combination of range modulator and scatterers spread the beam both laterally and 
longitudinally. The ionization chambers closer to the snout monitor the beam 
flatness and symmetry, as well as the amount of delivered dose. The beam is finally 
shaped at the snout by the aperture and the range compensator.  
 
A snout (Figure 2.9) is a removable component that contains the patient aperture 
and range compensator. The snout is attached at the end of a fixed beam delivery 
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system. The size of the snout varies depending on the treatment field size. The 
aperture is a patient specific custom milled collimator (Figure 2.10) that shapes the 
treatment field to a specific target profile. Usually, apertures are made out of brass 
because brass provides the best value in terms of price, weight, and production of 
secondary radiation. The patient specific range compensator is another custom 
made piece (Figure 2.10) which is used to shape the distal part of the dose 
distribution. Plastic material is commonly used for range compensator. The 
combination of patient aperture and range compensator conform the dose 
distribution to the contours of the treatment volume.  
 
 
Figure 2.10: A custom patient aperture (left), and a custom made range compensator 
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 Active Scanning Technique  2.6.2
 
The active scanning method is an alternative to the passive scattering method. In 
1980, Kanai et al. (Kanai et al., 1980) first suggested this alternative approach and 
later this technique was implemented at different facilities around the world 
(Albertini, 2011). The principle behind the active scanning system is essentially 
simple, i.e., protons are charged particles and can be deflected by magnetic fields. 
Using this approach, the narrow pencil beam is no longer required to be broadened 
by scattering method; instead it can be scanned over the treatment volume using 
appropriately varying magnetic fields. For this purpose, scanning magnets are used 
to generate the required magnetic fields so that the beam can be scanned onto the 
target. The scanning along the x-y plane of the treatment volume can be done using 
a particular magnetic field while scanning in depth is achieved by means of energy 
variation (Farr et al., 2008). The combination of the scanning ability and the energy 
variation allows this technique to place each individual Bragg peak anywhere inside 
the tumor volume.  
 
Active scanning systems are classified into two categories (Zheng et al., 2012): a) 
pencil beam scanning, and b) uniform scanning. The basic differences between 
pencil beam scanning and uniform scanning are: a) pencil beam scanning may not 
require any beam shaping components while uniform scanning system requires 
beam shaping components (Goitein, 2008), b) pencil beam scanning is capable of 
delivering a beam of variable intensity during scanning, while uniform scanning 
employs a beam of uniform intensity.  
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 Pencil beam scanning 2.6.2.1
 
Pencil beam scanning system uses scanning magnets to scan a narrow pencil beam 
(few mm) of variable intensity onto different planes (layers) of the treatment 
volume. The scanning along the depth is done by means of energy variation. A 
schematic diagram of a pencil beam scanning system is shown in Figure 2.11. In this 
method, scanning starts with the deepest layer of the target and covers a 
predetermined set of spots on that layer. The energy is then reduced and moves to a 
relatively shallower layer and covers all the predetermined spots on that layer 




Figure 2.11: Schematic diagram of spot scanning delivery system in proton radiotherapy.  
 
Pencil beam scanning can be done primarily in two different ways: spot scanning 
and raster or continuous beam scanning (Schlegel et al., 2006). In spot scanning, a 
constant magnet setting is used to deliver the dose to a given spot on a particular 
layer of the target (Kanai et al., 1980). After that spot is covered, the beam is then 
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turned off and magnet settings are changed to new values to irradiate the next spot. 
This process employs different magnet settings for different spots until all the 
predetermined spots on the tumor have been covered.  Raster or continuous beam 
scanning is very similar to the spot scanning method except that the beam is not 
turned off while it moves from one spot to the next. The beam remains on during the 
entire scanning process.  
 
 Uniform scanning  2.6.2.2
 
Uniform scanning system is recently developed beam delivery system. In general, a 
uniform scanning system is a hybrid of active scanning and passive scattering. This 
process uses sweeping magnets as like in active scanning to steer the beam and also 
beam shaping components (snout) as in passive scattering to conform the beam to 
the target. In this method, a beam of uniform intensity is used to scan different 
layers of the treatment volume. A schematic diagram of a uniform scanning system 
(IBA Louvian-la-neuve, Belgium) is shown in Figure 2.12.  
 
 




Figure 2.12: Schematic diagram of IBA uniform scanning nozzle. The components in the 
nozzle is not in scale.   
 
As shown in the figure, the proton beam passes through different beam shaping 
components, similar to the passive scattering system, except that instead of a second 
scatterer this method uses scanning magnet to cover lateral width of the treatment 
volume. The beam starts with the first scatterer, and then continues through the 
range modulator, scanning magnets, ionization chambers and finally the snout. The 
initial enlargement of the beam is done by the first scatterer. The combination of 
modulator wheel and the first scatterer lowers the beam energy to the required 
treatment depth. As the wheel rotates, the different thicknesses of absorber material 
adjust the beam to different depths of the treatment volume. As the beam passes 
through the modulator, the sweeping magnets deflect the beam by sweeping back 
and forth with a particular frequency. This creates a beam of uniform intensity 
commonly known as an uncollimated beam (Zheng et al., 2012). As the uncollimated 
beam continues, the ionization chambers monitor the beam symmetry, uniformity, 
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and the amount of delivered dose. Finally, the beam is shaped according to the 
tumor using the patient aperture and range compensator contained in the snout. 
 
The working mechanism of uniform scanning system is similar to pencil beam 
scanning. During scanning, the beam starts with the distal layer of the target and 
irradiates that layer. The beam then moves to a relatively shallower layer and 
irradiates that layer and the process continues until the proximal edge of the 
treatment volume is covered.  
 
This study investigates the dose equivalent due to secondary neutrons created by 
the uniform scanning system as described above. This uniform scanning system is 
currently in operation at the Procure Proton Therapy Center in Oklahoma City, OK. 
Both experiment and simulation work was carried out for this study. For the 
simulation, a simplified version of the uniform scanning system was used. See 
Sections 5.2 and 5.3 for details about the experimental and simulation set ups.  





3 SECONDARY NEUTRONS  
 
This chapter describes the nuclear processes responsible for secondary neutron 
production in proton radiotherapy. Dominant nuclear interactions for the 
production of secondary neutrons in therapeutic proton energies (50 to 250 MeV) 
are described. The level of neutron production largely depends on the design of the 
beam delivery device and on the primary proton energy. Neutron interactions with 
tissue and the reasons behind using water as alternative to tissue are also discussed.  
 
 Secondary neutrons in proton radiotherapy 3.1
 
In proton radiotherapy, different beam shaping components including the scatterer, 
range modulator, patient collimator and range compensator are used to conform the 
beam to the target. The interaction of energetic protons with these devices creates 
secondary particles through non-elastic nuclear interactions. The type and energy of 
the secondary particles produced in the interaction depend on the incident proton 
energy and the composition, density, and geometry of the interacting medium. 
These secondaries consist of different types of particles including neutrons, protons, 
electrons, alpha particles, and heavier fragments. Among them, the exposure from 
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neutrons could be potentially damaging as neutrons have higher relative biological 
effectiveness (RBE). 
 
The level of secondary neutron production strongly depends on the type of beam 
delivery system because each beam delivery system uses different beam shaping 
components. Of the various beam shaping components, the patient specific aperture 
can be a major source of secondary neutrons (Jiang et al 2005, Mesoloras et al 2006, 
Zheng et al 2007, Zacharatou Jarlskog et al 2008, Perez-Andujar et al 2009). In 
addition, because the patient specific aperture is placed close to the patient, 
neutrons produced in this component can contribute significantly to the total 
patient dose outside the treatment volume compared to the neutrons contribution 
from other components. It is important to note that during treatment, the field size 
is always chosen to be larger than the patient specific aperture. This is because the 
treatment facility is limited by the number of field sizes that an accelerator can 
produce. Due to this limitation, a significant portion of the beam is stopped by the 
aperture during treatment. This leads to higher rates of proton induced nuclear 
interactions and thus to increased production of secondary neutrons.  
 
Two nuclear processes, intranuclear cascade and nuclear evaporation are 
responsible for the production of secondary neutrons in the energy range of 50 to 
250 MeV primary protons (ICRU, 1978). Figure 3.1 shows a graphical 
representation of intranuclear cascade and evaporation process. For proton 
energies greater than 50 MeV, the intranuclear cascade process is particularly 
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important (Benton, 2004). In this process, protons, neutrons, alpha particles and 
occasionally heavier nuclei are produced as a result of nuclear interactions between 
incident particles and the target nucleus. The emitted particles in intranuclear 
cascade possess energy lower than the incident particles (Figure 3.1) and move in 
the forward direction, i.e. in the direction of the primary beam. These particles can 
undergo further nuclear interactions, known as an extra nuclear cascade. However, 
the probability to initiate an extra nuclear event in proton radiotherapy is small 
because the energy required for such events is greater than a few hundred MeV. The 
energy of the secondary neutrons due to intranuclear cascades start around  ~10 
MeV and can be as high as the incident proton energy (Zheng et al., 2007a).  
 
Figure 3.1: Illustration of intranuclear cascade and evaporation process  (ICRU, 1978).  
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The evaporation process, on the other hand, occurs in multiple steps processes 
following an intranuclear cascade. Alternatively, a target nucleus can absorb an 
incident proton or neutron and then undergo an evaporation interaction. After the 
release of the particles due to intranuclear cascade or the absorption of a proton or 
neutron, the target nucleus is often left in an excited and unstable state (Figure 3.1) 
and is referred as a compound nucleus (ICRU, 1978). The compound nucleus 
achieves stability by evaporating neutrons, protons, and alpha particles. The 
particles due to evaporation are emitted isotropically. The energy of the secondary 
neutrons due to evaporation process range from 0 to 10 MeV (Zheng et al., 2007a). 
The energy of the secondary neutrons created in proton radiotherapy primarily 
contains two peaks: a) peak due to evaporation neutrons (<10 MeV), and b) peak 
due to intranuclear cascade neutrons (>10 MeV). 
 
 Neutron interactions with matter   3.2
 
A neutron can interact with a target nucleus in a different number of ways, where 
the interaction probability depends on the energy of the incident neutron and the 
type of target nucleus. Various types of interactions can take place and the 
probability of any of such interaction is known as the cross section, having 
dimensions of area, i.e. cm2. An example of different types possible nuclear 
interactions is shown in Figure 3.2.   
 




Figure 3.2: Different types of neutron interaction (Rinard, 1991).    
 
As shown in Figure 3.2, two major types of interactions are possible: a) scattering, 
and b) absorption. Scattering events are further divided into elastic and inelastic 
interactions, whereas absorption events are categorized into electromagnetic, 
charged, neutral, and fission interactions. In scattering interactions, the incident 
neutron is scattered by a target nucleus and as a result of this interaction, the 
direction and speed of the incident neutron changes. In this process, the target 
nucleus remains intact, the total kinetic energy of the event is conserved and the 
internal states of the target nucleus and neutron remain unchanged. If the total 
kinetic energy in scattering is not conserved, the scattering is known as inelastic 
scattering. A fraction of energy in inelastic scattering is spent on the internal 
rearrangement of nucleons inside the nucleus (Rinard, 1991).  
     
In the absorption process, a neutron is absorbed by a target nucleus. Following 
absorption of a neutron by a target nucleus, the kinetic energy carried by the 
neutron will excite the nucleus to one of its higher energy states and the de-
excitation of the nucleus may lead to one of several outcomes: a) the emission of 
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electromagnetic radiation i.e. gamma rays, b) charged particles such as protons, 
deuterons, and alpha particles may emit, c) the emission of neutrons, and d) a 
fission event can take place, i.e. the nucleus can split into two or more fragments 
including neutrons (Rinard, 1991).  
 
The total cross section for neutron/target interactions is energy dependent. 
Depending on energy, neutrons are classified as: a) fast neutrons (> 500 keV), b) 
intermediate neutrons (10 keV-500 keV), c) epithermal neutrons (0.5 eV-10 keV), 
and d) thermal or slow neutrons (< 0.5 eV).  Fast and intermediate neutrons, in 
general, undergo scattering interactions while thermal or epithermal neutrons 
undergo absorption interactions.  
 
 Neutron’s interaction with tissue and the rationale for using water as tissue 3.2.1
replacement 
 
The interaction of neutrons on tissue depends on the interaction process of 
neutrons with each tissue component. The most common elements in human body 
are hydrogen, carbon, and oxygen and the total interactions depend on the 
individual interaction with each of these elements. Neutrons with energy greater 
than 1 MeV (fast neutrons) interact with carbon and oxygen nuclei in tissue through 
inelastic processes and can release alpha particles. These alpha particles deposit 
their energy to the tissue mass. Neutrons with energy 10 keV up to 1 MeV 
(intermediate energy neutrons) interacts elastically with the nuclei of hydrogen 
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atoms (protons). In this process, the energy transfer causes the creation of recoil 
protons while the incident neutron elastically scatters off a hydrogen nucleus. 
Thermal neutrons (< 0.5 eV), on the other hand, often transfer energy through the 
absorption process.  
 
 
The leading mechanism of energy transfer by neutrons to tissue is elastic scattering, 
where neutrons scatter of the hydrogen nuclei of water (Howell, 2010). This is 
because: a) the similar mass of hydrogen and neutron causes neutron to transfer 
maximum energy via elastic scattering, b) hydrogen has large neutron scattering 
cross section, and c) hydrogen is the most abundant element in tissue.   
 
An example of total cross sections for incident neutrons up to 20 MeV on hydrogen, 
carbon, and oxygen as a function of energy are shown in Figure 3.3 (NNDC, 2013). 
As can be seen from the figure, the total cross section of neutrons on carbon, 
hydrogen and oxygen either follows a decreasing trend with energy or stay constant 
with increasing neutron energy. The decreasing trend of total cross section is due to 
elastic interactions, while the constant trend is due to inelastic interactions. The 
peaks at around 0.1 to 10 MeV for carbon and oxygen nuclei are called resonance 
peaks. Resonance peaks occur when an incident neutron excites the target nucleus 
to one of its excited nuclear states. For the hydrogen nucleus (protons), resonance 
peaks are not visible because protons do not possess any excited nuclear states at 
these energies.  





























Figure 3.3: The average total cross section of neutron for carbon, oxygen and hydrogen as a 
function of incident neutron energy (NNDC, 2013).  
 
Figure 3.3 shows that hydrogen has about an order of magnitude greater total cross 
section than do carbon and oxygen for the same neutron energy. This means that 
hydrogen content in tissue dominates the neutron response. For this reason and 
also due to the similarity in the atomic mass percentages (Table 3.1) of hydrogen in 
water and in tissue (ICRU muscle), the difference in total cross section between 
water and ICRU muscle are negligible. This is shown in Figure 3.4, where the solid 
line represents the neutron cross section for neutrons on water and dotted line 
represents neutron cross section on ICRU muscle (for clarity, the total cross section 
on water is multiplied by a factor of 10).  Because of the similarity in total cross 
sections of neutron on water and ICRU muscle and since CR-39 plastic nuclear track 
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detector possesses a tissue like sensitivity to neutrons, this study uses water as 
tissue replacement in the FLUKA simulations.  
 
Table 3.1: Atomic percentages for ICRU muscle and water (ICRU, 1983). 
Content Atomic percentages (%) 
ICRU muscle water 
H 63.3 66.67 
C 6.4  
O 28.5 33.33 
Other 1.8  
 
Neutron Energy (MeV)






















ICRU Muscle X 10 
 
Figure 3.4: The average total cross section of neutron for ICRU muscle and water as a 
function of incident neutron energy(NNDC, 2013).  ICRU muscle cross section is multiplied 
by 10 in the graph to distinguish it from the cross section for neutrons on water .  





4 DOSIMETRIC QUANTITIES AND RADIATION LEAKAGE 
 
Dosimetric quantities are essential to quantify a given radiation environment. For 
example, the energy of the incident radiation per unit mass or absorbed dose is 
crucial in understanding the radiation exposure. But, absorbed dose alone cannot 
explain the radiation sensitivity of human tissue and that is why dose equivalent is 
measured. Dose equivalent is based on absorbed dose, but includes effectiveness in 
producing damage. This chapter describes the dosimetric quantities including 
particle fluence, LET (linear energy transfer), absorbed dose and dose equivalent. 
Dose equivalent using CR-39 plastic nuclear track detector is determined based on 
particle LET. In FLUKA simulations, fluence to dose conversion coefficients are used 
to determine dose equivalent. Standard guidelines for radiation leakage in radiation 
therapy are also described in this chapter.       
   
 Particle Fluence 4.1
 
Particle fluence is important for the quantification of radiation exposure in radiation 
therapy. According to the International Commission on Radiation Units and 
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Measurements (ICRU), particle fluence, , is defined as the number of particles,   , 
that cross a unit area,    (ICRU, 1998a): 
   
  
  
  (4.1)  
The SI unit of particle fluence is particles/m2. For isotropic or nearly isotropic 
situations, fluence is corrected for solid angle,   
   
  
    
  (4.2)  
where the unit is cm-2sr-1. 
 
 Linear Energy Transfer (LET) 4.2
 
Linear energy transfer (LET) refers to the energy deposition per unit path length by 
the charged particles as they travel through a medium. The term LET represents the 
local energy deposition in a medium and depends on the radiation type and the 
target material. LET is determined by the rate of energy loss in the medium as:  




where dE denotes the energy loss in the length, dl, of the stopping medium. The SI 
unit for LET is Joules/meter, but is more commonly expressed in keV/m.  
LET is related to mass stopping power and linear stopping power. The term mass 
stopping power (for a material of density of  ) for charged particles is represented 
as (ICRU, 1998b):   











  (4.4) 
The term S is the linear stopping power. Mass stopping power and linear stopping 
power are similar except that mass stopping power is independent of density of the 
material. The SI unit of mass stopping power is J.m2/kg but in practice usual has 
units of MeV·cm2/g. Mass stopping power includes the contributions from 



























   






 represents electronic stopping power due to collision with 




   
represents radiative stopping power due to 




   
represents nuclear stopping power due to 
elastic coulomb collisions. The leading contribution in stopping power is primarily 
due to electron collisions and can be estimated using the Bethe-Bloch formula 
described in Equation 2.1.  
 
According to ICRU report No. 60 (ICRU, 1998b), linear energy transfer (LET) is also 
referred as restricted linear stopping power,    , and can be expressed as:  
    
   
  
  (4.6) 
The term dEΔ in Equation (4.6) accounts the energy loss due to electronic collisions 
as the charged particles traverse through a medium of length dl. Equation (4.6) does 
not include the kinetic energy of secondary electrons freed from atoms in excess of 
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“Δ”. In other words, the subscript “Δ” sets the limit in eV above which the kinetic 
energy of secondary electrons is not included. ICRU Report No. 60 also presents 
Equation (4.6) as (ICRU, 1998a): 
          
     
  
  (4.7) 
 
 elec represents electronic stopping power and the second term specifies the sum of 
kinetic energies of secondary electrons released greater than  . The term    is 
known as the restricted linear stopping power and can also be written as   T . The 
linear stopping power that includes the kinetic energy of all the released secondary 
electrons is called unrestricted linear stopping power and is written as   T . For 
example,   T    R-   refers to the restricted linear stopping power in CR-39 PNTD 
without the kinetic energy of released secondary electrons greater than 200 eV, 
whereas   T     represents the total (or unrestricted) linear stopping power in 
water. In this study, unrestricted linear stopping power has been used to represent 
LET unless otherwise stated.  
 
 Absorbed dose and dose equivalent  4.3
 
Absorbed dose refers to the amount of energy, dE, absorbed per unit mass, dm, of a 
material as a result of radiation exposure and can be expressed as:  
   
  
  
   (4.8)  
SI unit of the absorbed dose is Gray (Joule/Kg). 
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 Dose equivalent refers the biological damage for an absorbed dose in matter. 
According to the International Commission on Radiological Protection (ICRP), dose 
equivalent is the product of the absorbed dose and LET dependent quality factor, Q 
(LET): 
           . (4.9)  
The SI unit of dose equivalent is the Sievert. 
 
The quality factor, Q, has been adopted from annex A of ICRP Publication No. 60 
(ICRP, 1991) as shown below: 
        {
    
            
    √    
 
             
                        





A plot of Q value against LET is shown Figure 4.1. It is important to mention that the 
quality factor is determined based on stochastic endpoints rather than deterministic 
endpoints. In stochastic processes there is no threshold for biological damage 
including the induction of cancer, whereas, in deterministic processes, a biological 
threshold is considered.  




Figure 4.1: Quality factor, Q, as a function of LET as defined in ICRP Publication No. 60 
(ICRP, 1991). 
 
 Determination of dose equivalent in CR-39 PNTD 4.3.1
 
For the determination of fluence, dose, and dose equivalent, from isotropic radiation 
on the surface of a CR-39 plastic nuclear track detector, consider the diagram shown 
in Figure 4.2.  




Figure 4.2: Geometry for solid angle calculation (Benton, 2004). 
 
The sphere is centered at a point O on the surface of a nuclear track detector, where 
r is the radius of the sphere. Using a spherical coordinate system, the differential 
area, dA, on the surface of the sphere is: 
                , (4.11) 
where 4π has been included to account for the isotropic nature of the incoming 
radiation and   represents the polar angle. From Figure 4.2, a relation between 
polar angle and dip angle δ (the angle at which particle intersect the detector 
surface) can be shown to be: 
          . (4.12) 
Substituting Equation (4.12) into Equation (4.11) and using the definition of solid 
angle, it can be shown that: 
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(4.13) 
Using the definition of fluence:   
 
  
   
    
 
(4.14) 





∫      ∫            
   
  
   
  The term δc represents the track registration dip angle, i.e. the maximum angle at 
which a track will form for a given value of LET. After a little mathematical 
manipulation it can be shown that: 
   
 
         
     
The term            
   is called weighting factor, W. Depending on the critical 
value δc, the weighting factor varies as a function of LET. Labeling each LET interval 
by j, the differential LET fluence can be expressed as: 
         .  
The integral LET spectrum can be found by adding the contribution from all LET 
intervals at which the integral fluence is measured: 
                ∑     
 
     
    
LETmin represents a lower threshold point at which the integral fluence is being 
counted.   Utilizing this differential LET spectrum, differential LET dose spectrum 
can be found in units of Gray as: 
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               (4.15) 
Similarly, the differential dose equivalent can be found by multiplying dose with the 
quality factor Q: 
    
          
 
                (4.16) 
Qj represents the quality factor dependent on LET interval. The total dose and dose 
equivalent can be found by summing the differential dose and dose equivalent over 
appropriate LET values.    
 
 Determination of dose equivalent using FLUKA  4.3.2
 
FLUKA uses fluence to dose equivalent conversion coefficients for the determination 
of dose equivalent. The coefficients are determined based on radiation weighting 
factor,     described in ICRP publication No 74 (ICRP, 1996). The subscript “R” 
represents the type of radiation. A list of radiation weighting factors,    for neutron 
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Table 4.1: Radiation weighting factor, wR, as defined in ICRP-60 (ICRP, 1991) 
for neutron of different energy range.   
                    Energy                                                                 
<10 keV                                                             5 
10 keV to 100 keV                                           10 
>100 keV                                                          20 
2MeV to 20 MeV                                              10 
>20 MeV                                                            5 
 
Radiation weighting factors are employed in the calculation of equivalent dose, HT,  
and is recommended by ICRP, in 1991 (ICRP, 1991), to replace the LET dependent 
dose equivalent. The equivalent dose, HT is (ICRP, 1991):   
    ∑       
 
 (4.17)  
where     is the absorbed dose average over the specific tissue or organ, T. There is 
another quantity related to dose equivalent is called effective dose and defined as, E 
(ICRP, 1991):   
   ∑      
 
 (4.18)  
where    is the weighting factor for the tissue, T. The effective dose accounts the 
sum of the weighted equivalent doses in all tissues and organs of the human body.  
 
FLUKA employs a spline fit over the conversion coefficients recommended by ICRP 
publication No 74 (ICRP, 1996) for the determination of dose equivalent. This is 
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shown in Figure 4.3, where fitted line is represented by AMB74 (red line) and ICRP 
coefficients are represented by ICRP74 (black star). As can be seen from the figure, 
the ICRP recommended conversion coefficients are limited to a few hundred MeV in 
neutron energy and undefined for the determination of dose equivalent at higher 
neutron energies. To circumvent this problem, Pelliccioni (Pelliccion, 1998) 
calculated conversion coefficients (blue diamond in the figure) for higher neutron 
energies using the technique suggested by ICRP and implemented in the FLUKA 
code (Roesler and Stevenson, 2006). The fitted curve AMB74 (red line) includes 
both the ICRP conversion coefficients and the coefficients extended by Pelliccioni. 
This study uses AMB74 for the calculation of dose equivalent from secondary 
neutrons. The term AMB74 in FLUKA represents the ambient dose equivalent 
conversion coefficients. According to ICRP, the ambient dose equivalent refers the 
dose equivalent which would be produced in the ICRU sphere (30 cm diameter) at a 








Figure 4.3: Ambient dose equivalent coefficients as a function of neutron energy. 
Plot taken from (Roesler and Stevenson, 2006). 
 
The reason behind the use of ambient dose equivalent in this study is that the 
current release of FLUKA does not include any code to calculate neutron equivalent 
dose. For this reason, it is difficult to assess the difference between neutron 
equivalent dose and ambient dose equivalent. To solve this problem, a study was 
carried by Halg et. al. (Halg et al., 2011), where absorbed dose and ambient dose 
equivalent were scored for neutrons from 10-7 to 103 MeV using 13 monoenergetic 
beams in FLUKA. The absorbed dose and ambient dose equivalent due to neutrons 
were calculated in an ICRP tissue mass of dimension 1 × 1 × 0.5 cm3. For each 
neutron energy, the neutron equivalent dose was then calculated by multiplying the 
average absorbed dose with the neutron weight factor     as shown in Equation 
(4.17), and a conversion coefficient from fluence to equivalent dose was established. 
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Using this process, the neutrons dose spectra created by protons inside a phantom 
were evaluated at 0, 5, 10, 15, 20, 25, and 30 cm depth. The ratio of neutron 
equivalent dose to ambient dose equivalent H*(10) is shown in Figure 4.4. 
 
 
Figure 4.4: Ratio of neutron equivalent dose to ambient dose equivalent calculated for a 
proton beam. Data taken from (Halg et al., 2011).  
  
As can be seen from this figure, the largest difference between the equivalent dose 
and ambient dose equivalent is less than 4%. Since the difference is much smaller 
than the uncertainty in the neutron dosimetry measurement themselves, the 
neutron dosimetry community considers neutron ambient dose equivalent as 
essentially identical to equivalent dose.  
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 Guidelines for secondary radiation exposure 4.4
 
At present, there are no active regulations or guidelines for the radiation leakage in 
proton or heavy ion therapy facilities (Moyers et al., 2008). Currently, most 
radiotherapy facilities follow the recommendations of the American Association of 
Physicists in Medicine (AAPM) for electron and x-ray therapy. In addition, some 
states in the USA have their own state regulations for radiation therapy. In 2006, the 
International Electro-Technical Commission (IEC) recommended that the physical 
dose due to leakage of primary particles downstream of beam line not exceed 2% of 
prescribed dose (Moyers et al., 2008). However, no recommendation for secondary 
neutrons was mentioned. It should be noted that neutron energy and fluence 
strongly depends on the design of the beam delivery system. Because of this, 
neutron fluence spectra vary between different proton therapy centers. In addition, 
due to limited human data on neutron exposure, the complexity of radiobiological 
effects and their ultimate clinical effect is not yet understood. For these reasons, any 
recommendations on secondary neutrons exposure in proton radiotherapy could be 
inadequate. However, as neutrons possess higher RBE than protons of similar 
energy exposure to neutrons could cause secondary cancers in patients undergoing 
treatment using proton radiotherapy.  





5 DETECTOR, EXPERIMENT AND SIMULATION 
 
 
In this study, both experiment and simulation approaches have been implemented 
to quantify off-axis neutron dose in proton radiotherapy. CR-39 plastic nuclear track 
detectors (PNTD) have been used to experimentally measure the neutron dose 
equivalent and Monte Carlo radiation transport Code FLUKA was used to simulate 
the experiment.  CR-39 PNTD can measure the dose from charged particles of 
  T       keV/µm and this allows for measurement of absorbed dose from 
secondary neutrons without measuring to absorbed dose from primary protons, 
since primary protons used in proton radiotherapy possess an   T     lower than 




This section describes different types of detector that are currently in use in proton 
radiotherapy for neutron detection. The rationale for using CR-39 PNTD is 
mentioned. The underlying principle behind the track formation in CR-39 PNTD and 
the importance of chemical etching procedure to enlarge the tracks is described. The 
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process of calibrating CR-39 PNTD to different ion/energy combinations is also 
mentioned.       
 
 Neutron detectors   5.1.1
   
Commonly used detectors in neutron dosimetry vary depending on the incident 
neutron energy. Historically, there are two widely used detectors in neutron 
dosimetry: Rem meters and Bonner spheres. Rem meters are more common in 
neutron detection in the area of health physics, while Bonner spheres are better 
suited as a laboratory instruments for the measurement of neutron energy spectra 
across a wide range of neutron energy.  
 
The term Rem stands Roentgen Equivalent Men, an early unit of dose equivalent. A 
Rem meter uses a gas filled detector, either BF3 or 3He, which have high neutron 
cross sections to thermal and slow neutrons. A thick layer of polyethylene 
moderator surrounding the detector is used to slow down the neutrons. After being 
moderated in energy, the low energy neutrons reach the detector region and are 
captured by the gas nuclei of the detector.  
 
Rem meter was originally developed in 1960s, where boron tri-fluoride (BF3) was 
used as detector filling gas. This is commonly known as a Snoopy meter. A Snoopy 
meter is very useful for the detection of neutrons from fission sources, i.e. from 
0.1 eV to 10 MeV. However, if the incident neutron energy is higher than 10 MeV, the 
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moderator is unable to thermalize these neutrons. This causes a significant decrease 
in neutron detection sensitivity. To accommodate higher energy neutrons, another 
type of Rem meter, known as the SWENDI Rem meter was designed in 1990s, where 
helium-3 (3He) is used as detector filling gas and the polyethylene moderator is 
embedded within a tungsten powder shell. When neutrons of higher energy pass 
through the moderator, the combination of tungsten powder shell and polyethylene 
can thermalize the higher energy neutrons. This increases the sensitivity of the 
meter up to 5 GeV.   
 
Another common type of neutron detector are Bonner spheres. Bonner spheres 
consist of polyethylene spheres of various diameters and 3He, BF3, or Li-glass 
scintillator as detector. In this type of detector, the increasing thickness of the 
sphere increases the detector response to higher energy neutrons because greater 
moderator thickness is needed to thermalize higher energy neutrons. Unfolding the 
neutron energy spectra from Bonner sphere requires the response of a detector to 
various energies and a standard algorithm to produce an approximate spectrum. 
This process involves greater uncertainty in the approximated neutron spectra.   
 
Although the use of a SWENDI detector is more common in proton radiotherapy 
than a Snoopy or a Bonner spheres, all these detectors possess the following 
limitations: a) they are bulky and cannot be placed inside a phantom for the 
measurement of organ equivalent dose, b) the sensitivity of these detectors varies 
depending on the incident neutron energy, c) and dose equivalent is measured from 
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fluence using fluence to dose equivalent conversion coefficients, adding greater 
uncertainty to the process.  For these reasons, experimental measurement of 
neutron dose in proton radiotherapy remains a challenging problem and this forces 
the community to pursue numerical simulations.  
 
An ideal, alternative detector in neutron dosimetry is CR-39 plastic nuclear track 
detector (PNTD). CR-39 plastic nuclear track detector (PNTD) is a transparent 
thermoset plastic polymer, polyallyldiglycol carbonate (C12H18O7). In 1970s, P.B. 
Price (Cartwright et al., 1978) first introduced CR-39 PNTD for cosmic ray research 
and around the same  time E.V. Benton (Cassou and Benton, 1978) first used it for 
radiation dosimetry.  Since then, CR-39 PNTD has been the most common type of 
solid state nuclear track detector (SSNTD) used in radiation dosimetry. CR-39 PNTD 
is sensitive to the charged particles of   T     from 5 to 1500 keV/µm. As  a 
result, CR-39 PNTD possesses a sensitivity to protons of energy   10 MeV, alpha 
particles of energy  200 MeV, and heavy ions (   ) for all energies.  Neutrons of 
energy between 1 and ~ 20 MeV are detected from recoil proton tracks produced in 
elastic interactions between neutrons and hydrogen nuclei of the detector material. 
Neutrons of energy greater than 20 MeV are detected via tracks from recoil heavy 
ions (from C and O nuclei) in non-elastic target fragmentation interactions.  
 
CR-39 PNTD is an ideal detector for neutron dosimetry in proton radiotherapy for 
the following reasons: a) CR-39 PNTD is made of a near-tissue equivalent polymer 
(composed of C, H, and O), i.e. it has tissue like sensitivity to the neutrons  (Benton et 
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al., 1986), b) the threshold LET (LETH2O 5           keV/µm) to register 
tracks in the detector is higher than the LET of the primary protons of the beam, so 
that primary protons do not create tracks, and c) unlike other detectors, CR-39 
PNTD is not bulky and can be placed at different locations inside a phantom to 
measure different organ doses.  
 
This study uses CR-39 PNTD for the entire experiment. CR-39 PNTDs used in this 
study were manufactured by American Technical Plastics, Inc., Stratford, CT, where 
each sheet was about 600 micrometer thick and each detector was cut to 4 x 4 cm2 
to place inside the phantom or in air.   
 
 Formation of tracks in CR-39 PNTD  5.1.2
 
When a charged particle passes through the detector material, it delivers part of its 
kinetic energy to the atoms surrounding its path and causes ionization and 
excitation. This primary ionization causes a large number of chemical bonds of the 
plastic to break along the particle’s trajectory. This path of chemically reactive 
broken bonds is called a latent damage trail. This latent damage trail is too small to 
observe by an optical microscope. For this reason, the detectors are etched in a 
highly reactive chemical solution (500C, 6.25 N NaOH for this work) for a set period 
of time to enlarge the tracks so that they are visible under an optical microscope. 
The chemical solution etches the detector at a rate higher along the latent damage 
trail than it etches the bulk of the plastic. The rate at which etching progresses along 
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the trail is called the track etch rate, VT, and the etching rate of the bulk of the plastic 
is called bulk etch rate, VB. Figure 5.1 illustrates such a nuclear track as a result of 
the chemical etching process. 
   
 
Figure 5.1 Nuclear track formation as a result of etching process (Henke and Benton, 
1971). 
 
Figure 5.1 shows a two dimensional view of the track etching process. The bulk etch 
rate VB propagates in all directions except along the damage trail and this property 
results in a three dimensional conical pit referred to as a nuclear track. The area of 
the elliptical opening of each conical pit is proportional to the LET of the incident 
particle that formed the track. For a nuclear track to be formed, the ratio of track 
etch rate to bulk etch rate, also known as reduced etch rate ratio, Vr, needs to be 
greater than 1. Alternatively, the track etch rate, VT, needs to greater than bulk etch 
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rate, VB. The reduced etch rate ratio, Vr, is an important parameter for the 
dimensions of the tracks since Vr is proportional to the LET of the charged particles 
that created the track. The reduced etch rate ratio, Vr, is (Henke and Benton, 1971):  
    
  
  
  (5.1) 
From Figure 5.1, the cone angle, θ, the angle between the wall of the track and the 
axis of the track, can be written in connection with the reduced track etch ratio as:  






         (5.2) 
 
To determine Vr, the semi major axis and semi minor axis of the elliptical opening of 
the tracks need to be measured. The semi major and semi minor axes depend on the 
cone angle θ, the dip angle δ (the angles at which particle hits the detector surface, 
Figure  5.2), and the bulk etch B (the amount of material removed in the etching 
process). Geometrically these parameters are illustrated in Figure  5.2.  The semi 
major axis, a, and semi minor axis, b, are related to the cone angle, θ,  and dip angle, 
δ, as shown in Equations (5.3) and (5.4) (Henke and Benton, 1971):  
 
   
     
         
   (5.3) 
 
   √
         
         
   
(5.4) 
   




Figure  5.2: Etched nuclear track with several geometrical parameters (Henke and Benton, 
1971). 
 
Using Equations (5.3) and (5.4), the reduced etch ratio, Vr, can be found (Benton, 
2004): 
    √









     (5.5) 
As mentioned above, Vr needs to be greater than 1 for track formation and this 
serves as an important condition for the determination of absorbed dose. The bulk 
etch,  , is determined from the difference in mass of the detector due to the etching 
process (Henke et al., 1986): 
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         ̅
   
(  
   ̅
  
)  (5.6) 
where    and    are the masses before and after etching,   ̅ is the mean post-etch 
thickness,   is the perimeter, and   is the one-sided surface area of the detector. 
 
 Importance of short-etch and long-etch methods  5.1.3
 
CR-39 PNTD is etched for a predetermined amount of time. For relatively accurate 
measurement of LET spectrum, use of both short-etch and long-etch methods are 
suggested. The usual duration of short-etch and long-etch in NaOH solution at 500C, 
6.25 N is 36 hours and 168 hours, respectively, corresponding roughly to B values of 
8 µm and 40 µm, respectively. This is because the shorter range particle that can be 
deleted by CR-39 PNTD is on the same order as the value of B. High LET short-range 
target fragments produced in nuclear interactions of highly energetic protons or 
neutrons with heavy nuclei of the detector material or the material near to it often 
have ranges < 40 µm. At the same time, some etching is required to make the track 
large enough to see with an optical microscope. A short etch of 8 µm serves as a 
compromise. In dosimetry of high energy neutons, fragments (most commonly C 
and O recoiled nuclei) contribute significantly to the LET (≥ 5 keV/µm) spectrum.  
 
The standard long etch method typically removes about ~40 µm of surface material 
and, therefore, removes tracks that might be formed from these short range target 
fragments. This ultimately leads to an error in the determination of the LET 
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spectrum. In order to overcome this error in LET determination, a second detector 




Figure 5.3: Cross sectional view of different types of track formed in PNTD (Benton, 2004). 
 
Figure 5.3 illustrates several track formation patterns and the reasons why LET 
spectra measured from a short-etch detector needs to be combined with 
measurements from a long-etch detector. In this figure, case a represents the 
situation where the particle travels through both pre-etch and post-etch surfaces of 
the detector and forms a standard elliptical track with sharp conical tip. This kind of 
tracks provides relatively accurate LET information. Case b represents a target 
fragmentation event which occurs in the layer removed by chemical etching and 
stops in the volume of the detector. Such tracks have sharp conical tip, but since the 
particles do not pass through the pre-etch surface, the tracks formed in this 
situation are smaller than they would be if they were passed through the pre-etch 
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surface. As a consequence, the LET for case b is under measured. Case c shows a 
track where the particle passes though the pre-etch surface and stops with in the 
volume of the detector. As can be seen from the figure, the end of the track is not 
sharp but rounded instead. This is because the etchant in this case reached deeper 
than the stopping point of the particle in the detector. This type of tracks is referred 
to as an over-etched track and without special treat LET will be over measured. Case 
d represents a combination of cases b and c, where the tracks are small and over-
etched. This case also leads to error in the LET measurement.  
In order to minimize the number of improperly measured tracks (cases b, c and d) 
without impacting measurement of the good tracks (case a), a short etch detector is 
used in addition to a long etch detector. Since a long etch detector is effective for low 
LET (≤ 50 keV/µm), a combination of short-etch and long-etch method covers the 
LET range from 5 to 1500 keV/µm. In this study, two layers of detectors were 
exposed under identical conditions, one of them was processed with long duration 
etch and the other was processed with a short duration etch.  
 
 Response of CR-39 PNTD  5.1.4
 
The response function of CR-39 PNTD is required to generate LET spectrum and 
eventually dose and dose equivalent from the tracks measured in the detector. For 
this purpose, a particular batch of CR-39 PNTD from the same manufacturer was 
exposed to various ion/energy combinations at two particle accelerators: HIMAC in 
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Japan, and the NASA Space Radiation Laboratory at the Brookhaven National 
Laboratory (BNL), USA. The aim is to expose the detector to particles of known LET, 
then measure the reduced etch ratio, Vr, and finally to plot LET200CR-39 versus Vr-1. 
A polynomial is then fit to determine LET as a function of the reduced etch rate 
ratio. This is because a fitted function to the plot of LET200CR-39 against Vr-1 best 
represents the track size with the LET of the particle, where LET200CR-39 represents 
the restricted energy loss from charged particles in CR-39 PNTD restricted to only 
the secondary electrons of energy ≤200 eV (Henshaw et al., 1981). The fitted 
polynomial for 168 hour etch is: 
                                             (5.7) 
and for 36 hour etch is:  
                                      , (5.8) 
 
where             and          T    R-   . The conversion of   T    R-   to 
  T     is done using the formula(Benton, 2004) : 
       T                        T    R      (5.9) 
This LET value represents the LET spectrum and later used for the calculation of 
dose and dose equivalent.  A linear correction was also made to the LET spectra for 
the measured tracks. This is because the measured LET spectra showed protons LET 
at ~120 keV/µm, but that should be within ~95 keV/µm.  The source of error in the 
LET spectra could be due to the temperature effect during the chemical etch. 
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 Experimental approach 5.2
 
The purpose of this study was to measure the off-axis dose equivalent outside the 
treatment volume produced by secondary neutrons. For this purpose, four different 
experimental configurations were designed to study the secondary neutrons created 
by the beam shaping components and by the phantom material. According to the 
setup, the experiments were named as solid-phantom, in-air, hollow-phantom, and 
cylindrical-phantom configurations. In all four configurations, CR-39 PNTDs were 
placed in nearly identical locations from beam isocenter. In solid-phantom 
configuration, layers of CR-39 PNTDs were placed inside a solid phantom to 
simulate the dose equivalent that a patient would receive in different organs during 
actual treatment. The in-air configuration was designed to observe the neutrons 
dose equivalent in the absence of a phantom. The hollow-phantom configuration 
was created by placing a hole along the beam direction in the solid phantom to 
observe the dose equivalent pattern if the primary beam does not interact with 
phantom material. The cylindrical phantom-phantom configuration was designed to 
observe the dose equivalent if the primary beam interacts only along the beam path 
in the phantom material.  
  
The dimension of each CR-39 PNTD detector used in the experiment was 
4 × 4 × 0.05 cm3. A polyethylene phantom of 0.96 gm/cm3 density was placed in 
front of the snout to represent a patient in solid-phantom configuration. The 
phantom was built by assembling polyethylene blocks, each having a dimension of 
     
75 
 
20 × 20 × 5 cm3. Using these blocks, a phantom of 60 cm in length and 20 cm in 
width was created for the experiment. As shown in the figure (Figure 5.4, top), three 
columns of polyethylene blocks were assembled to construct the phantom along the 
beam direction, where the thickness of the phantom differed along the length.  The 
thickness of the first and the third column was 35 cm, and the thickness of the 
second column was 52 cm to cover the 135° angled detectors.  
 
Figure 5.4, and Figure 5.5 represents the schematic diagram of the setup and the 
actual photograph of the experiment for solid-phantom and in-air configuration, 
respectively. In solid-phantom configuration (Figure 5.4), detectors were placed 
inside a solid phantom and located at 7.5 cm, 17.5 cm, 28 cm, and 35 cm from the 
beam isocenter at 45°, 90°, and 135° from the primary beam axis. In in-air 
configuration (Figure 5.5), no phantom was present and detectors were placed in 
the air at locations identical to those inside the solid-phantom configuration except 
at 90° where detectors were placed at larger distances from isocenter (40 cm and 
50 cm). Twelve set of CR-39 PNTDs were used for each experimental configuration.  
The dotted circles, in Figure 5.4, represent the detectors location inside the phantom 
but detector is not visible in the actual photograph. The filled circles and white 
rectangular objects illustrated in Figure 5.5, shows the detector location for in-air 
configuration. 
 





Figure 5.4: (top) Diagram of the solid-phantom experimental setup. Dotted circles represent 
the detectors locations inside the phantom (top). Picture was taken during the actual 










Figure 5.5: Diagram of the in-air experimental setup. Circles represent the detectors 
locations in the air. Picture was taken during the actual experiment (bottom).    
   
 
in-air 
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The schematic diagram of the setup and the actual photograph of the experiments 
for hollow-phantom and cylindrical-phantom are shown in Figure 5.6 and Figure 
5.7, respectively. The dotted circles, in Figure 5.6 , represent the detectors location 
inside the phantom but detector is not visible in the actual photograph. The filled 
circles and white rectangular object (in the photograph), in Figure 5.7, shows the 
detector location at cylindrical-phantom configuration. The photograph of the 
cylindrical-phantom configuration is also shown Figure 5.7. 
 
In hollow-phantom configuration (Figure 5.6), the dimension and the density of the 
phantom material was same as was in solid-phantom configuration, except that a 
5.5 cm diameter hole was bored along the center of the first column of polyethylene 
blocks of the phantom. The hollow part of the phantom was placed along the 
direction of the primary proton beam. Detectors were placed inside the phantom at 
7.5 cm, 17.5 cm, 28.5 cm, 35.5 cm for 45°, and 90°, but at 135° three detectors were 
used at 7.5 cm, 17.5 cm, 35.5 cm from beam isocenter. A total of eleven set of 
detectors were used in each experimental configuration. In cylindrical-phantom 
configuration (Figure 5.7), a cylinder (same phantom material) of 5.5 cm diameter 
and 35 cm length was placed along the beam direction. The detectors location from 
beam isocenter was identical to those inside the hollow-phantom configuration 













Figure 5.6: Diagram of the hollow-phantom experimental setup where dotted circles 
represent the detectors locations inside the hollow phantom (top), picture taken during the 
actual experiment (bottom).      
 
hollow-phantom 







Figure 5.7: Diagram of the cylindrical-phantom experimental setup where filled circles 
represent the detectors locations (top), picture taken during the actual experiment 
(bottom).      
cylindrical-phantom 
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Three proton beams of 78 MeV, 162 MeV, and 226 MeV were used for all the 
experimental configurations. A common set of treatment parameters was used: a 4 
cm spread out Bragg peak (SOBP), a 5 cm diameter patient brass aperture, a 10 cm 
from surface to isocenter, a 28 cm distance from snout to surface of the phantom, a 
18 x 18 cm2 uncollimated beam, and no range compensator. These treatment 
parameters will treat a patient of imaginary tumor of 5 cm diameter and 4 cm width. 
The air distance was chosen 28 cm to replicate commonly used value (20-30 cm) in 
proton radiotherapy. It is to be noted that air distance is patient dependent. For 
example, in ocular cases or in head and neck, air distance is carefully chosen to 
improve the dose fall-off pattern at the distal end of the target in order to avoid the 
dose in critical structure. The isocenter inside the phantom was chosen 10 cm to 
replicate more common practical scenario. No compensator was used in this 
experiment because no dose conformation was required around the contour of the 
treatment volume. Also, range compensator is usually made of plastic and it does 




This section describes the basic approach used in Monte Carlo radiation transport 
codes employ for modeling a simple experiment. An introduction is given on the 
radiation transport code FLUKA. The simulation of a simplified snout for uniform 
scanning proton beam is described. The interaction of the proton beam with 
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different components of snout and the production of secondary particles and their 
propagation is also shown graphically.      
 
 The Monte Carlo radiation transport code FLUKA 5.3.1
 
The term Monte Carlo refers to the use of a repeated random sampling technique for 
the simulation of a physical event. The probable behavior of a physical event can be 
simulated from the outcome of a large number of trials of that system, where each of 
the trials is simulated by a computer and based on a sequence of random numbers. 
By using random numbers, this method simulates a physical problem via z 
probabilistic approach and is sometimes called a virtual experiment. 
 
In simulations of secondary neutron production in the ProCure beam delivery 
system, the physical behavior of the problem is predicted by the interaction of 
proton beam as it passes through the complex mass distribution represented by the 
beam delivery system and a phantom patient. Individual primary proton’s 
interaction with the geometrical mass distribution at each point along proton’s 
trajectory is determined via the probability of the many different interactions 
processes (cross sections). The outcome of the interaction at each point is 
determined based on weighted random numbers. This process also includes the 
probability of the generation of secondary particles and the probability of 
interactions of these secondary particles with the mass. This process continues until 
all the particles produced as a result of the incident primary proton either stop or 
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leave the volume of interest. The calculation progresses repeatedly due to a large 
number of primary protons so as to obtain convergence on an average with good 
statistics. Finally, different parameters, e.g., LET, dose, or dose equivalent are scored 
by adding up the outcomes at a particular location of interest within the volume.         
 
This study uses the Monte Carlo radiation transport code FLUKA for the simulation 
of the experiment. FLUKA is an integrated Monte Carlo radiation transport code that 
is widely used in many areas of physics and engineering including high energy 
experimental physics, cosmic ray research, medical physics, shielding design for 
radiotherapy vaults, radiation detector design, etc. (Andersen et al., 2004, Aiginger 
et al., 2005, Ballarini et al., 2007, Battistoni et al., 2007, Fassò et al., 2005). FLUKA 
was primarily developed to model the secondary radiation environment produced 
by particle accelerators at the European Organization for Nuclear Research (CERN). 
Later, the code was adapted for use in medical physics for the calculation of 
dosimetric quantities including LET, dose, and dose equivalent. The interaction of 
sixty different particles and their propagation inside the matter can be simulated 
using FLUKA. Electrons and photons from 1 keV to thousands of TeV, neutrons 
down to thermal energy, hadrons of up to 20 TeV,  and all the corresponding anti 
particles can be tracked down with excellent accuracy.  
 
FLUKA consists of three main components: a) geometry, b) physics, and c) scoring. 
In the beginning, the geometry of the problem is described in terms of combinatorial 
geometry. In this process, basic bodies like cylinders, spheres, parallelepipeds, etc. 
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are combined using Boolean operations (addition, subtraction, union, etc.) to 
describe complex 3D mass distribution of the problem. The material properties are 
then assigned to each object. After the geometry of the problem is fully described, an 
additional region called the “black hole” must be defined surrounding the region of 
interest. The purpose of the “black hole” is to halt the simulation of particles that 
leave the region of interest.  
 
The physics component sets the appropriate cross sections such as those for 
inelastic nuclear interactions, and elastic scattering, and nucleus-nucleus 
interactions for a particle to propagate through the matter (FLUKA, 2013). FLUKA 
can also transport particles based on the energy of those particles. This enhances 
the efficiency since user can decide to propagate only particles within a given 
energy range and ignore particles with energy below this range. This capacity can 
effectively reduce the computation time. The transport of all particles except 
neutrons can be enabled for energies as low as 1 keV. Neutrons can be transported 
to even lower energies, i.e. 10-5 eV. The cross sections for neutron interactions is 
divided into 260 energy groups (Ferrari et al., 1997) with the lowest energy being 
10-5 eV. The secondary electron production threshold (minimum energy required to 
produce a secondary electron) can be as low as 1 keV for all particles except 
neutrons.  
       
The scoring component determines the quantity of interest in the region of interest. 
Since FLUKA estimates quantities using probabilistic approach, the scored quantity 
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always possess an uncertainty. The greater the number of primary particles in the 
simulation, the better is the statistical uncertainty. FLUKA can score a large number 
of quantities including particle fluence, dose, dose equivalent, beam current, LET, 
track length, energy spectra, Z spectra, and energy deposition.  
 
In this work, the transport and secondary electron production thresholds were both 
set to 100 keV for all particles except neutrons. This means that all particles except 
neutrons with energy equal to or greater than 100 keV were transported. The 
transport and threshold value could be decreased to 1 keV, but such a low energy 
threshold would significantly increase the computation time. To score dose 
equivalent, a separate routine was used for neutrons of energy 1 to 20 MeV, because 
the interaction cross section for water decreases significantly for neutrons with 
energy greater than 20 MeV. In all the locations, dose equivalent was calculated with 
a statistical uncertainty equal to or less than 10%.  
 
 Simulation of simplified snout 5.3.2
 
In the simulation, a simplified snout, currently in use at ProCure Proton Therapy 
Center, Oklahoma City, OK, was modeled. The simplified snout consists of a snout 
base (brass), a snout wall (stainless steel), and a patient specific aperture (brass). 
Cross sectional and FLUKA geometry diagrams of the snout geometry are shown in 
Figure 5.8.  
 




Figure 5.8: The cross sectional diagram of the snout (top), FLUKA geometry generated 
diagram of the snout (bottom). The snout is used at ProCure Proton Treatment Center, 
Oklahoma City, OK (Figure not drawn to scale).   
 
The choice of simplified snout was made based on the fact that it contains the major 
neutron producing components of the beam delivery system. Neutron production in 
the range modulator and range compensator were not considered since they are 
composed of mostly low-Z material and the production of neutron in low-Z material 
was not considered to be significant. Among different components, by far the largest 
contribution from secondary neutrons to the patient comes from the patient 
aperture. The patient aperture is composed of brass and placed close to the patient. 
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For this reason, about 80% to 90% of the total secondary neutrons that may reach 
the patient come from the patient aperture. This is why the simulation of the 
simplified snout is adequate for the study of secondary neutrons and their 
respective contribution to the total dose equivalent.  
 
The simulation was carried for identical treatment parameters and beam energies 
as described in the experimental section. Water was chosen as the material of the 
detector because, like water, CR-39 PNTD has a tissue-like sensitivity to neutrons. 
The dimension of the detector, placement of detector, dimensions of the phantom, 
phantom material, exactly mimics the same experimental design. All four 
experimental configurations were simulated.  
 
 Beam interaction with snout and phantom 5.3.3
 
As described in the experiment, an uncollimated beam of 18 × 18 cm2 was used in 
the simulation. The beam of 18 × 18 cm2 cross sectional area was created by 
defining appropriate divergence of the beam. According to beam commissioning 
report for the ProCure Proton Therapy Center, Oklahoma City, Ok (Zheng et al., 
2011), a 18 × 18 cm2 beam in front of the patient aperture is equivalent to a point 
source of protons that uniformly diverge to a 20 × 20 cm2 area after travelling 
through 2 m in air. This beam was then allowed to propagate through the snout, 
where the patient aperture shapes the unmodulated field down to 5 cm diameter, 
after which it passed into the phantom.  
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The interaction of the beam with the snout and the phantom in 3D is shown in 
Figure 5.9. This plot illustrates how the proton point source diverges for the 
purpose of creating an 18 × 18 cm2 unmodulated field in front of the aperture. As a 
result of interaction of the beam with the snout, secondaries (blue lines) are 
produced and scatter in all directions. This plot was created for a very low number 
of primary protons (103) for 162 MeV proton beam. However, for the determination 
of the dose equivalent at each location, about ~108 primary protons were 
transported. A 2D view of the beam interaction with the snout and phantom is 
shown in Figure 5.10.  
 
 
Figure 5.9: FLUKA simulated 3D view of a 162 MeV proton beam interacting with the snout 
and phantom.  
 




Figure 5.10: FLUKA simulated 2D view of 162 MeV primary beam interaction with snout 
and the phantom. 





6 EXPERIMENT AND SIMULATION METHODS 
 
This chapter presents the readout method of the CR-39 PNTDs used in this study. An 
example of LET spectrum, dose spectrum and dose equivalent spectrum are plotted 
using the data obtained from the CR-39 PNTDs. The method of determining SOBP in 
the FLUKA simulations is described. Simulated SOBP for three different beam 
energies- 78 MeV, 162 MeV, and 162 MeV-is also shown.      
 
 Analysis of CR-39 PNTDs   6.1
 
This section describes the read-out method of CR-39 PNTDs. The instrument used to 
analyze the CR-39 PNTD and the method to determine the LET, dose and dose 
equivalent spectra are described. Examples of LET, dose and dose equivalent 
spectra from both short-etch and a long-etch detectors are shown.  
  
 CR-39 PNTDs read-out process 6.1.1
 
After the chemical etch, CR-39 PNTDs were analyzed using standard optical 
microscope. The readout process consists of locating all the tracks within a given 
Normalized dose 
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area on the surface of the etched detector and measuring the semi major axis, a, and 
a semi minor axis, b, of each individual track. A photomicrograph illustrating the 
tracks formed on the surface of CR-39 PNTD is shown in Figure 6.1, where the semi 
major and semi minor axis is visible in the inset picture.  
 
 
Figure 6.1: A photomicrograph of the tracks formed on a sample CR-39 PNTD detector. The 
inset shows the semi-major, a, and semi-minor, b, axes labeled on a nuclear track.  The field-
of-view has dimensions of 682 × 524 µm.  Each nuclear track is ~16 µm in diameter. 
 
PNTD analysis used a Samaica nuclear track detector system manufactured by 
ELBEK GmbH, Siegen, Germany (Trakowski et al., 1984, Dreute et al., 1986, Wiegel 
et al., 1986, Noll et al., 1988, Rusch et al., 1991). The ELBEK computerized 
microscope system consists of a light illuminated optical microscope, a CCD camera, 
a computer controlled x-y stage, an autofocus system, a video frame grabber and a 
PC, as shown in Figure 6.2. Customized software is used for the detection and 
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analysis of the photomicrograph image. In the readout process, a PNTD is first 
placed on the x-y microscope stage and then the computer calibrates the stage to a 
predefined set of coordinates. A particular objective is chosen for the scanning of the 
tracks. After calibration, the customized software is used to capture the image and 
to fit the circular and elliptical tracks of that image. The result of the fitting 
parameters such as semi major, semi minor axis, dip angle is saved as a text file for 
further processing.   
 
Figure 6.2: Photograph of Track detector analysis system used to read-out CR-39 PNTDs 
(Dewitt, 2011). 
 
This text file is further processed using a MATLAB program developed for this 
experiment. This program generates LET spectrum, dose and dose equivalent from 
the track data contained in the text file. This processing involves, a) the 
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determination of reduced etched ratio, VR , from the semi-major, a, and semi-minor, 
b, axes using Equation (5.5), b) calculation of   T    R-   from detector response 
function shown in Equation (5.7) or (5.8), c) conversion of   T    R-   to 
  T     using Equation (5.9).  
 
A generated differential fluence LET spectra for a 162 MeV proton beam inside the 
phantom at solid-phantom configuration at 35.5 cm from isocenter and 90° to 
primary beam is shown in Figure 6.3.  The data is shown for both long-etch (blue 
line) and short-etch (red line) detector. Since long-etch detectors cannot register 
short range tracks of relatively higher LET, a cross over point in the range from 30 
to 100 keV/µm is usually chosen to combine the two LET spectra into a single 
spectrum. The combined LET spectrum as shown in Figure 6.4 is used for measuring 
the dose and dose equivalent. The integral fluence is then generated from this 
combined LET spectrum as shown in Figure 6.5. The integral plot starts adding the 
contribution of higher LET first and then continues adding up till the lowest LET 
value. The variable slope of the plot indicates the contributions of various LETs to 
the total spectrum. The relatively steep slope in the region, 20 to 50 keV/µm, 
illustrates the greater contribution of these LETs to the integral spectrum, whereas 
the leveling off of the spectrum below 10 keV/µm indicates that the LET below 10 
keV/µm does not contribute much to the total fluence.  
 
 































Figure 6.3: Differential LET fluence spectrum for 162 MeV proton beam for solid-phantom 




























Figure 6.4: Combined LET differential fluence spectrum of long-etch and short-etch detector 
of 162 MeV proton beam for solid-phantom configuration at 35.5 cm from isocenter and 90° 
to the primary proton beam.  


























Figure 6.5: Integral LET fluence spectrum combining long-etch and short-etch detector of 
162 MeV proton beam inside the solid phantom at 35.5 cm from isocenter and 90° to the 
primary proton beam   
 
 
An integral LET dose and dose equivalent plot is shown in Figure 6.6 and Figure 6.7 
respectively. The plots of dose and dose equivalent show that although the higher 
LET (>100 keV/µm) tracks are less abundant, their contribution to the total dose 
and dose equivalent is significant. The near flat slope <70 keV/µm in the integral 
dose equivalent plot shows that the total dose equivalent does not change much for 
the LET less than 70 keV/µm. The dose or dose equivalent at the lowest LET in the 
integral plots indicate the total contribution of the quantity of interest. This 
procedure was used for determining the total dose (Equation 4.15) and dose 
equivalent (Equation 4.16) at each detector location.  
 




















Figure 6.6: Integral LET dose spectrum combining long-etch and short-etch detector of 
162 MeV proton beam inside the solid phantom at 35.5 cm from isocenter and 90° 
























Figure 6.7: Integral LET dose spectrum combining long-etch and short-etch detector of 162 
MeV proton beam  inside the solid phantom at 35.5 cm from isocenter and 90 degree to the 
primary proton beam   




 Simulation of SOBP  6.2
 
This section describes the method that is used to simulate SOBP using FLUKA. In 
addition, the method to determine dose equivalent is also described. Calculated 
SOBP for all three beams used in this study is shown.     
   
 Calculation of SOBP 6.2.1
 
For the simulation of the SOBP, the effect of each layer of the range modulator was 
simulated by running an individual primary beam of a specific energy. A weighting 
factor, wi, was assigned for each layer and the dose for the SOBP was calculated by 
performing a weighted sum:  
     ∑  
 
        6.1 
The subscript, i, represents the number of the beam used in the process to produce 
the SOBP. The distal peak (highest energy) carries the highest weight and the 
proximal peak (lowest energy) carries the lowest weight.  
 
A calculation of a 4 cm SOBP for the 226 MeV proton beam is explained in this 
section. The first step was to determine the distal and proximal edge of the desired 
SOBP. For a 226 MeV proton beam, the distal edge is 32 cm in water.  To cover a 4 
cm SOBP depth, the proximal edge needs to be at 28 cm, corresponding to a 208.5 
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MeV proton beam. Two more energies, 219 MeV and 213 MeV were used in between 
the distal and proximal edge for the overall uniformity of dose.  Each beam was then 
run for the individual Bragg-peak.  The dose at each Bragg-peak was then used to 
produce the SOBP by doing a weighted sum following Equation 6.1. The Bragg-peak 
of each individual beam and the weighted SOBP for 226 MeV protons is shown in 
Figure 6.8.  The generated SOBP of 78 MeV, 162 MeV, and 226 MeV proton beam is 
shown in Figure 6.9. 
 
 
Figure 6.8: Bragg-peak of individual primary proton beam and the calculated SOBP for the 









Figure 6.9: The generated SOBP for 78 MeV, 126 MeV and 226 MeV proton beam. 
  
Figure 6.9 shows that the dose uniformity in the SOBP region is better for the 226 
MeV proton beams compared to 162 MeV and 78 MeV. This is because the width of 
the Bragg-peak is inherently greater for 226 MeV protons than the other two beams 
and this makes the SOBP region more uniform.  The relatively larger width of the 
Bragg-peak for higher energy occurs due to the range straggling effect.  In order to 
make a more uniform SOBP dose region for the 162 MeV and 78 MeV proton beams, 
a large number of beams could be used. However, this is not practical in an actual 
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After being determination of SOBP, the SOBP dose is used to normalize the dose 














Hn/p represents the dose equivalent due to secondary neutrons per unit primary 
proton and Dp/p represents the dose at SOBP per unit primary proton. Hn/Dp 
represents the ratio of dose equivalent due to secondary neutrons to primary 
proton dose. This method is used in this study to represent the FLUKA simulated 
neutron dose equivalent, where for each energy ~108 primaries and 5 different runs 
were performed to produce the dose equivalent at each detector’s location.  







This chapter presents the off-axis dose equivalent results from secondary neutrons 
at different locations in all four experimental configurations. Several layers of 
CR-39 PNTDs were placed inside the phantom (solid-phantom and hollow-phantom 
configurations) and in the air (in-air and cylindrical-phantom configurations) for the 
determination of dose equivalent. The dose equivalent values due to experiment and 
simulation are shown as the ratio of dose equivalent to absorbed proton dose 
(Hn/Dp) at each detector location. Hn/Dp as functions of distance, energy, and angle 
are presented. Comparisons of measured and simulated Hn/Dp for different 
configurations are also described.       
    
 Hn/Dp for solid-phantom, in-air, hollow-phantom, and cylindrical-phantom 7.1.1
configuration 
 
Table 7.1 lists the experimentally measured and FLUKA simulated dose equivalent 
Hn/Dp values due to solid-phantom, in-air, hollow-phantom, and 
cylindrical-phantom configurations for a 78 MeV proton beam. Hn/Dp is listed at 
each detector’s location for different angles and distances inside the phantom and in 




air. The angle was measured from primary beam direction and the distance of the 
detector was measured from the beam isocenter. For the solid-phantom 
configuration (inside the phantom), the experimentally measured Hn/Dp values 
ranged from 0.31±0.08 mSv/Gy to 7.47±1.42 mSv/Gy and the FLUKA simulated 
Hn/Dp values ranged from 0.11 ± 0.01 mSv/Gy to 3.81 ± 0.02 mSv/Gy. For the in-air 
configuration (in the air), the experimentally measured Hn/Dp values ranged from 
2.50±0.22 mSv/Gy to 9.25±1.48 mSv/Gy and the FLUKA simulated Hn/Dp ranged 
from 1.21 ± 0.06 mSv/Gy to 5.12 ± 0.27 mSv/Gy. For the hollow-phantom 
configuration (inside the phantom), the experimentally measured Hn/Dp values 
ranged from 2.12 ± 0.19 mSv/Gy to 7.31 ± 0.78 mSv/Gy and the FLUKA simulated 
Hn/Dp values ranged from 0.13±0.01 mSv/Gy to 7.29 ± 0.02 mSv/Gy. For the 
cylindrical-phantom configuration (in the air), the experimentally measured Hn/Dp 
values ranged from 2.72±0.28 mSv/Gy to 35.61 ± 1.48 mSv/Gy and the FLUKA 
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 Table 7.1: Experimentally measured and FLUKA simulated ratios of neutron dose 
equivalent to proton absorbed dose (Hn/Dp) for a 78 MeV primary proton beam at detector 
locations in the solid-phantom, in air, inside the hollow-phantom, and outside the 















































1.35±0.10 1.51 ± 0.02 7.5 6.71±1.21 2.71±0.12 
17.5 0.85±0.06 0.43 ± 0.01 16.3 
 
4.12±0.50 2.11±0.07 
28.5 0.56±0.11 0.21 ± 0.01 28.5 3.91±0.31 1.52±0.08 







2.36±0.15 1.91 ± 0.02 12.5 6.61±0.41 3.41±0.17 
17.5 1.24±0.11 0.52 ± 0.02 18.2 2.71±0.16 2.82±0.12 
28.5 0.71±0.11 0.23 ± 0.01 40 1.42±0.07 2.23±0.11 










7.5 7.47±1.42 3.81 ± 0.02 9.3 9.25±1.48 4.31±0.21 
18.2 1.71±0.11 1.41 ± 0.02 17.2 6.53±0.87 5.03±0.26 
25.5 1.12±0.07 1.02 ± 0.02 29.5 3.24±0.21 5.12±0.27 
35.5 2.31±0.17 1.43 ± 0.01 33 3.11±0.21 4.71±0.23 











7.5 4.68±2.14 2.14±0.15 7.5 9.64±1.01 8.21±0.41 
17.5 3.29±1.09 1.11±0.07 16.3 
 
5.15±0.51 6.66±0.31 
28.5 2.47±0.22 0.41±0.03  28.5 4.27±0.41 6.15±0.29 







3.01±0.36 3.97±0.23 7.5 15.98±1.45
1 
9.36±0.75 
17.5 2.61±0.29 1.64±0.09 17.5 7.95±0.65 8.94±0.71 
28.5 2.33±0.27 0.51±0.02 32 6.68±0.58 4.57±0.41 




7.5 7.31±0.78 7.29± 0.71 7.5 35.61±1.48 11.41±0.41 
17.5 3.23±0.32 3.61±0.32 17.5 9.08±0.87 9.41±0.32 
35 4.88±0.54 4.47±0.41 35 6.25±0.21 10.56±0.42 
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Figure 7.1 shows the dose equivalent per proton absorbed dose (Hn/Dp) for a 
78 MeV proton beam for solid-phantom configuration.  Solid lines are the 
experimentally measured data and dotted lines are the FLUKA simulated data. In 
general, Hn/Dp decreases as a function of distance for both measured and simulated 
data at all angles (45°, 90°, and 135°) inside the phantom. This is expected because 
as the distance from the beam isocenter increases, more neutrons are attenuated 
inside the phantom, leading to a decrease in Hn/Dp with distance. An exception is 
that an increase of Hn/Dp is observed at 35.5 cm at 135°. The reason behind the 
increase is: a) at 135, the detector was closer to snout which led to a higher 
neutron fluence, and b) at 35.5 cm, the detector was closer to the front surface of the 
phantom, causing the neutrons not to be attenuated as much as they would have at 
greater depths in the phantom.  
 
Figure 7.2 shows the experimentally measured and FLUKA simulation data of Hn/Dp 
as a function of distance from isocenter for a 78 MeV proton beam for in-air 
configuration. A decreasing trend in Hn/Dp with distance is again visible in air except 
that at 135° an increase of Hn/Dp with distance is visible in the FLUKA simulated 
result. Overall, higher values of Hn/Dp can be seen in air versus inside the phantom 
at all angles. 
 


































Figure 7.1: Experimentally measured (solid) and FLUKA simulated (dotted)neutron dose 
equivalent per therapeutic proton absorbed dose, Hn/Dp, for a 78 MeV proton beam inside 
the phantom for solid-phantom configuration at increasing distances from isocenter at 45, 
90 and 135 to the direction of the beam. 
































Figure 7.2: Experimentally measured (solid)and FLUKA simulated (dotted) neutron dose 
equivalent per therapeutic proton absorbed dose, Hn/Dp, for a 78 MeV proton beam in the 
air for in-air configuration at increasing distances from isocenter at 45, 90 and 135 to the 
direction of the beam. 
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To help clarify the increased Hn/Dp values in air with distance at 135 in the FLUKA 
simulated data (dotted black line in Figure 7.2), a FLUKA simulation of the neutron 
fluence spectrum for a 78 MeV proton beam for the in-air configuration at 135 to 
the primary beam is shown in Figure 7.3. This plot is shown for neutrons of energy 
from 1 to 20 MeV, since Hn/Dp was scored in this energy range. As can be seen, at 
smaller distance (9.3 cm), the fluence is lower while at larger distance (33 cm), the 
fluence is higher. This is because at larger distances from isocenter (33 cm), the 
detector is actually closer to the snout where a significant number of neutrons are 
present due to evaporation processes. This higher fluence of neutrons leads to 
higher dose equivalent in the FLUKA simulated results. However, at 135 the 
experimentally measured Hn/Dp value (solid black line in Figure 7.2) shows a 
decrease in dose equivalent as the distance increases. The disagreement between 
experiment and simulation at 135 could be due to the following reasons: a) closer 
to the snout the primary contribution mostly comes from low energy isotropic 
neutrons of about 1 MeV, where CR-39 PNTD just starts registering tracks from 
neutrons, b) differences in the way dose equivalent is calculed, i.e. FLUKA converts 
fluence to dose equivalent by using tabulated conversion coefficients, while CR-39 
PNTD measures dose equivalent based on the incident particle’s   T, and c) the 
difference in actual neutron cross section as exhibited in CR-39 PNTD versus the 
tabulated and interpolated cross section library used in FLUKA.  






























Figure 7.3. FLUKA simulated neutron energy spectra from a 78 MeV proton beam for 
the in-air configuration at 135 and 9.3 cm, 17.2 cm, 29.5 cm, and 33 cm distances 
from beam isocenter.  
 
Figure 7.4 shows the experimentally measurements and FLUKA simulations of 
Hn/Dp as a function of distance from isocenter for the hollow-phantom 
configuration. In general, Hn/Dp decreases as a function of distance at all angles (45°, 
90°, and 135°). An increase in Hn/Dp is again observed at 35 cm at 135° inside the 
phantom. This is because in the hollow-phantom configuration, detectors were 
placed inside the phantom at the same locations as inside the solid-phantom 
configuration. Figure 7.5 shows experimental measurements and FLUKA 
simulations of Hn/Dp for the 78 MeV proton beam for the cylindrical-phantom 
configuration. A decreasing trend in Hn/Dp with distance is again visible for the 
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cylindrical-phantom configuration and is similar to that observed for the in-air 
configuration.   
 































Figure 7.4: Experimentally measured (solid) and FLUKA simulated (dotted) neutron dose 
equivalent per therapeutic proton absorbed dose, Hn/Dp, for a 78 MeV proton beam for 
hollow-phantom configuration at increasing distances from isocenter at 45, 90 and 135 
to the direction of the beam. 



































Figure 7.5: Experimentally measured (solid) and FLUKA simulated (dotted) neutron dose 
equivalent per therapeutic proton absorbed dose, Hn/Dp, for a 78 MeV proton beam for 
cylindrical-phantom configuration at increasing distances from isocenter at 45, 90 and 
135 to the direction of the beam. 
 
A general decrease in Hn/Dp was observed in all these configurations both inside the 
phantom (solid-phantom and hollow-phantom) and in air (in-air and 
cylindrical -phantom) for a 78 MeV proton beam. Also, at 135° to primary beam an 
increase in Hn/Dp was observed at larger distances from beam isocenter for all the 
configurations.  This is due to this particular location actually being closer to the 
snout, where many secondary neutrons are produced, than the other locations. 
 
 
Table 7.2 lists the experimentally measured and FLUKA simulated Hn/Dp values for 
the solid-phantom, in-air, hollow-phantom, and cylindrical-phantom configurations 
for a 162 MeV proton beam. For the solid-phantom configuration (inside the 
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phantom), the experimentally measured Hn/Dp values ranged from 
1.29±0.17 mSv/Gy to 12.95±1.72 mSv/Gy and the FLUKA simulated Hn/Dp values 
ranged from 1.01±0.06 mSv/Gy to 19.31±0.24 mSv/Gy. For the in-air configuration 
(in the air), the experimentally measured Hn/Dp values ranged from 3.74±0.61 
mSv/Gy to 22.61±2.51 mSv/Gy and the FLUKA simulated Hn/Dp values ranged from 
9.91±0.34 mSv/Gy to 33.21±0.53 mSv/Gy.  For the hollow-phantom configuration 
(inside the phantom), the experimentally measured Hn/Dp values ranged from 
2.25 ± 0.22 mSv/Gy to 29.49 ± 2.51 mSv/Gy and the FLUKA simulated Hn/Dp values 
ranged from 2.73 ± 0.31 mSv/Gy to 39.92 ± 2.71 mSv/Gy. For the 
cylindrical-phantom configuration (in the air), the experimentally measured Hn/Dp 
values ranged from 10.12 ± 0.81 mSv/Gy to 50.01 ± 3.5 mSv/Gy and the FLUKA 
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Table 7.2: Experimentally measured and FLUKA simulated ratios of neutron dose equivalent 
to proton absorbed dose (Hn/Dp) for a 162 MeV primary proton beam at detector locations 
for solid-phantom, in-air, hollow-phantom, and cylindrical-phantom configuration. All the 












































17.5 2.31±0.27 5.41±0.35 16.3 
 
10.58±1.36 16.01±0.38 
28.5 2.04±0.25 2.01±0.21 28.5 5.26±0.72 11.72±0.35 









12.5 12.21±1.26 26.01±0.52 
17.5 4.05±0.82 4.71±0.24 18.2 8.39±1.27 21.02±0.42 
28.5 2.21±0.12 2.12±0.07 40 4.76±0.75 17.02±0.47 






9.3 22.61±2.51 33.21±0.53 
18.2 4.12±0.42 13.32±0.6
5 
17.2 13.25±1.46 39.31±0.71 
25.5 3.01±0.41 10.21±0.2
0 
29.5 7.82±1.01 39.22±0.78 
35.5 4.21±0.40 12.51±0.2
1 
33 8. 6±1.12 36.52±0.73 
                                    hollow-phantom 
 
 








7.5 7.68±0.71 16.17±1.56 7.5 45.72±3.31 71.81±5.23 
17.5 5.83±0.53 14.08±1.41 16.3 
 
21.01±2.35 41.14±2.36 
28.5 3.78±0.37 7.17±0.65 28.5 14.89±1.32 28.45±2.27 







8.11±0.74 34.53±3.89 7.5 37.45±3.77 65.97±5.27 
17.5 3.60±0.61 8.97±1.07 17.5 15.01±1.19 55.67±4.38 
28.5 3.22±0.46 6.23±0.75 32 7.92±0.71 46.03±3.65 




7.5 29.49±2.51 39.92±2.71 7.5 50.01±3.51 82.22±9.11 
17.5 7.58±0.71 27.25±1.12 17.5 15.51±1.13 89.18±6.23 
35 16.38±1.65 29.72±1.56 35 16.56±1.32 62.50±6.54 
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Figure 7.6: Experimentally measured (solid) and FLUKA simulated (dotted) neutron dose 
equivalent per therapeutic proton absorbed dose, Hn/Dp, for a 162 MeV proton for 
solid-phantom configuration at increasing distances from isocenter at 45, 90 and 135 to 
the direction of the beam. 
































Figure 7.7: Experimentally measured (solid) and FLUKA simulated (dotted) neutron dose 
equivalent per therapeutic proton absorbed dose, Hn/Dp, for a 162 MeV proton beam for the 
in-air configuration at increasing distances from isocenter at 45, 90 and 135 to the 
direction of the beam. 
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Figure 7.6, Figure 7.7, Figure 7.8, and Figure 7.9 represents the Hn/Dp for a 162 MeV 
proton beam for solid-phantom, in-air, hollow-phantom, and cylindrical-phantom 
configurations, respectively. A general decrease in Hn/Dp was observed for all these 
configurations both inside the phantom (solid-phantom and hollow-phantom) and 
in the air (in-air and cylindrical -phantom). Similar to the 78 MeV proton beam, an 
increase in Hn/Dp inside the phantom was observed at 35.5 cm distance at 135° to 
primary beam direction. In air, the FLUKA simulated Hn/Dp also increased as a 
function of distance.    
 
Distance (cm)






























Figure 7.8: Experimentally measured (solid) and FLUKA simulated (dotted) neutron dose 
equivalent per therapeutic proton absorbed dose, Hn/Dp, for a 162 MeV proton beam for 
hollow-phantom configuration at increasing distances from isocenter at 45, 90 and 135 
to the direction of the beam. 
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Figure 7.9: Experimentally measured (solid) and FLUKA simulated (dotted) neutron dose 
equivalent per therapeutic proton absorbed dose, Hn/Dp, for a 162 MeV proton beam for 
cylindrical-phantom configuration at increasing distances from isocenter at 45, 90 and 
135 to the direction of the beam. 
Table 7.3 lists the experimentally measured and FLUKA simulated Hn/Dp values for 
the solid-phantom, in-air, hollow-phantom, and cylindrical-phantom configurations 
for a 226 MeV proton beam. For the solid-phantom configuration (inside the 
phantom), the experimentally measured Hn/Dp values ranged from 
1.81 ± 0.42 mSv/Gy to 37.11 ± 1.72 mSv/Gy and the FLUKA simulated Hn/Dp values 
ranged from 2.51 ± 0.14 mSv/Gy to 69.21 ± 1.11 mSv/Gy. For the in-air 
configuration (in the air), the experimentally measured Hn/Dp values ranged from 
4.82 ± 0.61 mSv/Gy to 37.41 ± 2.42 mSv/Gy and the FLUKA simulated Hn/Dp values 
ranged from 24.81 ± 0.82 mSv/Gy to 85.31 ± 1.81 mSv/Gy.  For the hollow-phantom 
configuration (inside the phantom), the experimentally measured Hn/Dp values 
ranged from 2.09 ± 0.21 mSv/Gy to 25.42 ± 2.33 mSv/Gy and the FLUKA simulated 
Hn/Dp values ranged from 10.95 ± 0.89 mSv/Gy to 135.66 ± 6.71 mSv/Gy. For the 
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cylindrical-phantom configuration (in the air), the experimentally measured Hn/Dp 
values ranged from 10.21 ± 0.94 mSv/Gy to 46.20 ± 3.96 mSv/Gy and the FLUKA 
simulated Hn/Dp values ranged from 50.06 ± 1.23 mSv/Gy to 153.15 ± 8.51 mSv/Gy.   
 
Figure 7.10, Figure 7.11, Figure 7.12, and Figure 7.13 show Hn/Dp as a function of 
distance from beam isocenter for a 226 MeV proton beam for solid-phantom, in-air, 
hollow-phantom, and cylindrical-phantom configurations, respectively. A general 
decrease in Hn/Dp was observed for all configurations both inside the phantom 
(solid-phantom and hollow-phantom) and in the air (in-air and 
cylindrical-phantom) configurations. Similar to the 78 MeV and 162 MeV proton 
beams, an increase in Hn/Dp inside the phantom was observed at a distance of 
35.5 cm at 135° to the primary beam direction. In the air, the FLUKA simulated 
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Table 7.3:  Experimentally measured and FLUKA simulated ratios of neutron dose 
equivalent to proton absorbed dose (Hn/Dp) for a 226 MeV primary proton beam at detector 
locations for solid-phantom, in-air, hollow-phantom, and cylindrical-phantom 


















































28.5 2.82±0.61 5.01±0.25 28.5 7.82±1.01 30.11±0.91 

















28.5 4.81±0.57 5.52±0.25 40 8.53±1.11 45.02±1.26 
35.5 3.92±0.47 
± 











































28.5 4.37±0.39 8.52±0.65 28.5 19.47±1.73 53.27±0.98 
35.5 3.93±0.38 12.98±1.0
3 









7.5 46.20±3.96 131.35±1.23 
17.5 5.05±0.53 30.96±2.5
6 
17.5 21.16±1.74 85.95±1.32 
28.5 3.27±0.32 11.39±1.0
1 
32 12.61±1.19 85.44±1.56 






7.5 45.79±3.61 153.15±8.51 
17.5 13.46±1.23 71.99±3.6
4 
17.5 16.95±2.75 163.48±7.45 
35 22.46±2.21 81.11±4.0
4 
35 29.62±1.71 153.36±6.25 
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Figure 7.10: Experimentally measured and FLUKA simulated neutron dose equivalent per 
therapeutic proton absorbed dose, Hn/Dp, for a 226 MeV proton beam inside the phantom at 
increasing distances from isocenter at 45, 90 and 135 to the direction of the beam. 
 


































Figure 7.11: Experimentally measured and FLUKA simulated neutron dose equivalent per 
therapeutic proton absorbed dose, Hn/Dp, for a 226 MeV proton beam in air at increasing 
distances from isocenter at 45, 90 and 135 to the direction of the beam. 






































Figure 7.12: Experimentally measured and FLUKA simulated neutron dose equivalent per 
therapeutic proton absorbed dose, Hn/Dp, for a 226 MeV proton beam for hollow-phantom 
at increasing distances from isocenter at 45, 90 and 135 to the direction of the beam. 
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Figure 7.13: Experimentally measured and FLUKA simulated neutron dose equivalent per 
therapeutic proton absorbed dose, Hn/Dp, for a 226 MeV proton beam for 
cylindrical- phantom set up at increasing distances from isocenter at 45, 90 and 135 to 
the direction of the beam. 
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The overall uncertainty in the experimentally measured Hn/Dp values were 
estimated to be 20%, while for the FLUKA simulation data, the uncertainty was less 
than or equal to 10%. For all configurations, both inside the phantom and in air, the 
simulated result agreed with experiment within a factor of 3 at most of the 
locations, but in few locations the agreement varied by up to a factor of 9.   
 
 Comparison of Hn/Dp among different configurations 7.1.2
 
Figure 7.14 and Figure 7.15 show the comparison of Hn/Dp between solid-phantom 
and in-air configurations for the experimentally measured and FLUKA simulated 
results, respectively. Figure 7.16 and Figure 7.17 shows the comparison of Hn/Dp 
between hollow-phantom and cylindrical-phantom configurations, for the 
experimentally measured and FLUKA simulation results, respectively. The results 
are shown for three different energies, 78 MeV, 162 MeV and 226 MeV, and three 
different angles, 45, 90, and 135. Solid lines represent Hn/Dp inside the phantom 
(solid-phantom and hollow-phantom) and dotted lines represent Hn/Dp in air (in-air 
and cylindrical-phantom). The hollow-phantom configuration is labeled as “hop” 
and cylindrical-phantom configuration is labeled as “cyp” in the figures.   
 
In general, Hn/Dp is higher in air than inside the phantom for all three angles. This is 
due to the fact that more neutrons were stopped, i.e. fewer neutrons reached the 
detector locations, inside the much denser phantom than in air. The largest 
difference in Hn/Dp between in-air and solid-phantom configurations and between 
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hollow-phantom and cylindrical-phantom configurations was observed for the 78 
MeV proton beam. The experimentally measured Hn/Dp values varied by up to a 
factor of 7, while the FLUKA simulation Hn/Dp values varied by up to a factor of 18. 
This is probably due to the fact that secondary neutrons from 78 MeV proton are 
lower in average energy compared to the neutrons produced by 162 MeV and 226 
MeV proton beam. For this reason, neutrons from 78 MeV are more easily 
attenuated inside the phantom than in air compared to neutrons from 162 MeV and 
226 MeV proton beam.  
 
The general trend of higher Hn/Dp values in air at all angles for both experiment 
(Figure 7.14 and Figure 7.16) and FLUKA simulation (Figure 7.15 and Figure 7.17) 
shows that the production of neutrons by beam shaping components (external 
neutrons) is much greater than the production of neutrons inside the phantom 
(internal neutrons). It is important to note that the phantom may produce 
significant numbers of thermal and epithermal neutrons (less than 1 MeV) but since 
CR-39 PNTD is not sensitive to neutrons in this energy regime, this study (both 
experiment and simulation) neglected neutrons of energy less than 1 MeV.  
 
     
121 
 





































































































Experimentally measured solid-phantom versus in-air
 
Figure 7.14: Experimentally measured dose equivalent per therapeutic proton absorbed 
dose, Hn/Dp, for 78MeV, 162 MeV, and 226 MeV proton beam for solid-phantom and in-air  
configuration at increasing distances from isocenter at 45, 90 and 135 to the direction of 
the beam.  







































































































FLUKA simulated solid-phantom versus in-air
 
Figure 7.15: FLUKA simulated dose equivalent per therapeutic proton absorbed dose, Hn/Dp, 
for 78 MeV, 162 MeV, and 226 MeV proton beam for solid-phantom and in-air configuration 
at increasing distances from isocenter at 45, 90 and 135 to the direction of the beam. 
 





























































































Experimentally measured hollow-phantom vs cylindrical-phantom
 
Figure 7.16: Experimentally measured dose equivalent per therapeutic proton absorbed 
dose, Hn/Dp, for 78MeV, 162 MeV, and 226 MeV proton beam for hollow-phantom (labeled 
as hop) and cylindrical-phantom (labeled as cyp) configuration at increasing distances from 
isocenter at 45, 90 and 135 to the direction of the beam.  
 





























































































FLUKA simulated hollow-phantom vs cylindrical-phantom
 
Figure 7.17: FLUKA simulated dose equivalent per therapeutic proton absorbed dose, Hn/Dp, 
for 78MeV, 162 MeV, and 226 MeV proton beam for hollow-phantom (labeled as hop) and 
cylindrical- phantom (labeled as cyp) configuration at increasing distances from isocenter 
at 45, 90 and 135 to the direction of the beam.  
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In the hollow-phantom configuration, the contribution of internal neutrons to Hn/Dp 
should be small since the primary beam passed through the phantom without 
interacting with phantom material. On the other hand, in the cylindrical-phantom 
configuration, the contribution of internal neutrons to the Hn/Dp due to the protons 
interaction with phantom material should be substantial. For example, at 17.5 cm 
from beam isocenter and 90 to the primary beam, the experimentally measured 
Hn/Dp for a 226 MeV proton beam is 5 mSv/Gy and 21 mSv/Gy for the 
hollow-phantom and cylindrical-phantom configurations, respectively. The higher 
Hn/Dp for the cylindrical-phantom compared to hollow-phantom configuration 
suggests that the contribution due to internal neutrons could be added to that from 
external neutrons. However, a higher Hn/Dp (Figure 7.14 and Figure 7.15) for the 
in-air configuration compared to solid-phantom configuration was also observed 
even though there was no source of internal neutrons present. Considering this, it is 
not possible to predict the contribution of internal neutrons based on the four 
configurations.  
 
To study the difference in Hn/Dp inside the phantom, a comparison of Hn/Dp for the 
162 MeV proton beam is shown for the solid-phantom and hollow-phantom 
configurations. Figure 7.18 and Figure 7.19 shows the experimentally measured and 
the FLUKA simulation Hn/Dp values inside the phantom for the 162 MeV proton 
beam, respectively. In general, a higher Hn/Dp was observed in the hollow-phantom 
(dotted line) than in the solid-phantom configuration (solid line). Ideally, in the 
hollow-phantom configuration, fewer internal neutrons are expected and the total 
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Hn/Dp at each location should be less compared to the same locations inside the 
solid-phantom configuration. However, these results again suggest that the 
contribution of internal neutrons is much smaller than the contribution of external 
neutrons to locations off-axis to the treatment volume.   
 
To study the difference in Hn/Dp in the air, a comparison of Hn/Dp for 162 MeV 
proton beam is shown for in-air and cylindrical-phantom configurations. Figure 
7.20, and Figure 7.21 shows the experimentally measured and FLUKA simulated 
Hn/Dp values in air for the 162 MeV proton beam, respectively. Both experimentally 
measured and FLUKA simulation results show a higher Hn/Dp in 
cylindrical-phantom configuration (dotted line) than in the in-air configuration 
(solid line). This result suggests that the contribution of internal neutrons from the 
cylindrical phantom could be added to that from external neutrons or that a greater 
scattering of the external neutrons by the cylindrical phantom leads to an increased 
in Hn/Dp. For this complicated situation, it is again not possible to quantify Hn/Dp due 
to internal neutrons based on these four configurations.  
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Figure 7.18: Experimentally measured Hn/Dp values as a function of distance from isocenter 
inside the phantom for solid-phantom and hollow-phantom configurations for a 162 MeV 
proton beam at 45, 90, and 135 to primary beam. 































Figure 7.19: FLUKA simulated Hn/Dp values as a function of distance from isocenter inside 
the phantom for solid-phantom and hollow-phantom configurations for a 162 MeV proton 
beam at 45, 90, and 135 to primary beam. 
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Figure 7.20: Experimentally measured Hn/Dp  values in air as a function of distance from 
isocenter for in-air and cylindrical-phantom configuration for a 162 MeV proton beam at 
45, 90, and 135 to primary beam. 
































Figure 7.21: FLUKA simulated Hn/Dp values in air as a function of distance from isocenter for 
in-air and cylindrical-phantom configurations for a 162 MeV proton beam at 45, 90, and 
135 to primary beam. 
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 Hn/Dp dependence on energy 7.1.3
 
To study the dependence of Hn/Dp on energy, the detector at 17.5 cm from isocenter 
and at 90 to the primary beam is chosen for all four configurations. The diagram of 
the setup is shown in Figure 7.22 for the solid-phantom and in-air configurations 




Figure 7.22: Diagram of the locations where dose equivalent was calculated at 17.5 cm from 
isocenter in solid-phantom (top) and in-air (bottom) configuration. 
 


































Figure 7.23: Experimentally measured (solid) and FLUKA simulated (dashed) Hn/Dp 
at 17.5 cm and 90 to primary beam for 78 MeV, 162 MeV and 226 MeV protons for 
solid-phantom, in-air, hollow-phantom, cylindrical-phantom configurations. 
 
Figure 7.23 shows both the experimentally measured and FLUKA simulation Hn/Dp 
values at 17.5 cm and 90 to the primary beam for 78 MeV, 162 MeV and 226 MeV 
proton beams. As the energy of the primary beam increases, the dose equivalent due 
to secondary neutrons increases. The highest Hn/Dp was observed for 226 MeV 
proton beam and Hn/Dp progressively decreased for 162 MeV and 78 MeV proton 
beams. For example, the experimentally measured Hn/Dp value for the 
solid-phantom configuration decreased from 6.64 ± 0.92 mSv/Gy for 226 MeV 
protons to 1.24 ± 0.11 mSv/Gy for 78 MeV protons, while for in-air configuration, 
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Hn/Dp decreased from 11.51 ± 1.31 mSv/Gy for 226 MeV protons to 2.71 ± 0.16 
mSv/Gy for 78 MeV protons. The FLUKA simulation Hn/Dp for the solid-phantom 
configuration decreases from 11.51 ± 0.52 mSv/Gy for 226 MeV protons to 
0.52 ± 0.02 mSv/Gy for 78 MeV protons, while for the in-air configuration, the Hn/Dp 
decreased from 57.41 ± 1.32 mSv/Gy for 226 MeV protons to 2.11 ± 0.17 mSv/Gy 
for 78 MeV protons. For both experiment and simulation, a greater Hn/Dp is found 
for higher energy and lower Hn/Dp is found for lower energy inside the phantom 
(solid-phantom and cylindrical-phantom) and in air (hollow-phantom and 
cylindrical-phantom). This is expected because higher energy protons create more 
neutrons when they undergo nuclear interactions in the beam delivery device and in 
the phantom material, causing greater Hn/Dp at higher energy. The effective beam 
scan area is also an important parameter in neutron production, since a larger beam 
scan area results in greater neutron production. In this study, a common beam scan 
area of 18 × 18 cm2 was used and since the scan area was substantially greater than 
the size of the patient aperture (5 cm diameter) used in this study, a greater portion 
of the field size was stopped by the patient aperture. This caused the 226 MeV 
undergo more nuclear interactions within the aperture, leading to greater neutron 
production compared to 162 MeV and 78 MeV proton beam.  
 
 
 Hn/Dp dependence on angle 7.1.4
 
To study Hn/Dp as a function of angle, the detectors at 17.5 cm distance from the 
beam isocenter was chosen for all four configurations. The diagram of the setup is 
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similar to that value shown in Figure 7.22. Both experimentally measured (solid) 
and FLUKA simulation (dashed) Hn/Dp values for a 162 MeV proton beam are shown 
in Figure 7.24. As can be seen from this figure, as the angle increases from 45 to 
135, Hn/Dp, in general, also increases. For example, as the angle increase from 45 
to 135, Hn/Dp for the solid-phantom configuration increases by up to a factor of 1.8 
in the experiment and by 2.4 in the simulation. For the in-air configuration, the 
increase factor is 1.3 in the experiment and 2.5 in the simulation. The higher Hn/Dp 
at 135 suggests that a patient will receive greater Hn/Dp at the locations closer to 
the snout. Although, the general trend of higher Hn/Dp is visible as the angle 
increases, at 90 a decrease in Hn/Dp (in-air and hollow-phantom) was observed in 
the experimentally measured result as the angle increased. It could be that in the 
45 detectors, the forward moving neutrons (>~10 MeV) make a significant 
contribution in addition to isotropic neutrons (<10 MeV), but that at 90 the 
contribution from forward moving neutrons becomes less, leading to the decrease 
seen in Hn/Dp.  At 135, the fluence from isotropic neutrons becomes higher as they 








































Figure 7.24: : Experimentally measured (solid) and FLUKA simulated (dashed) 
Hn/Dp as a function of angle at 17.5 cm for a 162 MeV proton beam for 
solid-phantom, in-air, hollow-phantom, cylindrical-phantom configurations. 
 
 
 Experiment versus simulation  7.1.5
 
In order to compare results from the FLUKA simulation and experimentally 
measured Hn/Dp values, the ratio of FLUKA simulation to experimentally measured 
data is shown in Figure 7.25. In this figure, it can be seen that FLUKA simulation 
results for each proton beam agrees reasonably well with the experimentally 
measured data. The agreement is in general within a factor of 2 to 4 for most 
locations inside the phantom (solid-phantom and hollow-phantom) and in air (in-air 
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and cylindrical-phantom) but at a few locations, the disagreement is up to a factor of 
9.  
Distance (cm)






















































































































































Figure 7.25: Ratio of FLUKA simulation to experimentally measured values of Hn/Dp 
for 78 MeV, 162 MeV, and 226 MeV protons for solid-phantom (top left), in-air (top 
right), hollow-phantom (bottom left), and cylindrical-phantom (bottom right) 
configuration. 
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The agreement is better inside the phantom than in air. Inside the phantom, the 
largest disagreement between experiment and simulation is about a factor of 6, and 
in air this is about a factor of 9. The disagreement is higher for the 162 MeV and 
226 MeV proton beams compared to the 78 MeV proton beam. The source of error 
in this disagreement could be the followings: a) the lack of detail in the simulation of 
the geometry of the uniform scanning system, and b) a difference in neutron cross 
sections in experiment and FLUKA simulation. For the energy range (78 MeV to 226 
MeV) used in this study, the CR-39 PNTD detector sensitivity is nearly constant and 
this suggest that FLUKA calculated Hn/Dp could be systematically high for all the 
configurations.  
 





8 Discussion and Conclusions 
 
 
The primary aim of this study was to quantify the dose equivalent due to secondary 
neutrons for three different primary proton energies, 78 MeV, 162 MeV, and 226 
MeV in proton radiotherapy. We investigated the detailed spatial distribution of 
secondary neutron dose equivalent to primary proton dose, Hn/Dp, inside a phantom 
and in air for a fixed aperture size, fixed SOBP, and a fixed snout to surface distance 
using a uniform scanning system at the ProCure Proton Therapy Center, Oklahoma 
City, OK. Four different configurations, named as solid-phantom, in-air, 
hollow-phantom, and cylindrical-phantom, have been designed for the purposes of 
this study. The study was carried out by means of both experiment and simulation, 
where CR-39 plastic nuclear track detector was used as detector for the experiment 
and the simulations were performed using the Monte Carlo radiation transport code 
FLUKA. In solid-phantom configuration, a solid phantom was used to simulate the 
dose equivalent that a patient would receive in different organs during actual 
treatment. The in-air configuration was designed to observe the neutrons dose 
equivalent in the absence of a phantom. The hollow-phantom configuration was 
created by placing a hole along the beam direction in the solid phantom to observe 
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the dose equivalent if the primary beam does not interact with phantom material. 
The cylindrical phantom-phantom configuration was designed to observe the dose 
equivalent if the primary beam interacts only along the beam path in the phantom 
material.  
 
Table 8.1: The maximum and minimum Hn/Dp from experiment and simulation of this study 
inside the phantom due to solid-phantom and hollow-phantom configuration and in air due 









(in-air and cylindrical-phantom) 
 
Maximum Minimum Maximum Minimum 
                                        Experiment 
78 7.47 ± 1.42 0.31 ± 0.08 35.61 ± 1.48 1.35 ± 0.08 
162 29.49 ± 2.51 1.29 ± 0.17 50.01 ± 3.51 3.74 ± 0.61 
226 37.11 ± 2.41 1.81 ± 0.42 45.79 ± 3.61 4.82 ± 0.61 
       FLUKA simulation 
78 7.29 ± 0.71 0.13 ± 0.01 1.21 ± 0.06 11.41 ± 0.41 
162 1.01±0.06 39.92 ± 2.71 82.22 ± 9.11 9.91 ± 0.34 
226 2.51 ± 0.14 135.66 ± 6.78 153.15±8.51 24.81 ± 0.82 
 
 
For all these configurations, the ratio of dose equivalent from secondary neutrons 
calculated outside the treatment volume to primary proton dose, Hn/Dp, was 
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observed to decrease as a function of distance from beam isocenter.  Table 8.1 lists 
the experimentally and FLUKA simulated data for maximum and minimum Hn/Dp 
inside the phantom (solid-phantom and hollow-phantom) and in air (in-air and 
cylindrical-phantom) for all four experimental configurations. In this study, the 
experimentally measured Hn/Dp for both inside the phantom and in air ranged from 
0.31 ± 0.08 mSv/Gy to 35.61 ± 1.48 mSv/Gy for 78 MeV, 1.29 ± 0.17 mSv/Gy to 
50.01 ± 3.51 mSv/Gy for 162 MeV, 1.81 ± 0.42 mSv/Gy to 37.11 ± 2.41 mSv/Gy for 
226 MeV. The FLUKA simulated Hn/Dp ranged from 0.13 ± 0.01 mSv/Gy to 
11.41 ± 0.41 mSv/Gy for 78 MeV, 1.01 ± 0.06 mSv/Gy to 82.22 ± 9.11 mSv/Gy for 
162 MeV, 2.51 ± 0.14 mSv/Gy to 153.15 ± 8.51 mSv/Gy for 226 MeV proton beam. In 
addition, both inside the phantom and in air, Hn/Dp due to secondary neutrons 
increased as the energy of the primary proton beam increased and a higher Hn/Dp 
was also observed as the angle increased. In general a good agreement between 
experimentally measured and FLUKA simulated data was observed. Inside the 
phantom, the experimentally measured and FLUKA simulated Hn/Dp agreed within a 
factor of 4 and in air the agreement varied up to a factor of 9.  
  
This data suggests that the neutron dose equivalent for a uniform scanning system 
in a common proton treatment facility may range from 0.3 mSv/Gy to 50 mSv/Gy. 
The higher Hn/Dp in air than that of inside the phantom suggests that the production 
of neutrons in the beam shaping components is much higher than inside the 
phantom.  
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For the verification of this study and to compare the Hn/Dp from uniform scanning 
with other mode of beam delivery system, a comparison of our experimentally 
measured data with published literature is made and shown in  
Table 8.2. These comparisons are not exact as patient specific parameters, snout 
design, and beam delivery system varies from one facility to the other.  
 
Table 8.2: Comparison of this work with previously published results at different treatment 
facilities: ProCure Proton Therapy Center at Oklahoma, USA (ProCure), Midwest Proton 
Radiotherapy Institute (MPRI), the Paul Scherrer Institute Proton Therapy Facility 
Switzerland (PSI), the Harvard Cyclotron Laboratory, USA (HCL), the Loma Linda University 













This work 78 uniform 35 4 0.49 
ProCure , OKC 
(Zheng et al., 
2012) 
78 uniform 35 4 0.35 
MPRI (Hecksel 
et al., 2010) 
 
151 uniform 40 10 0.8 
PSI (Schneider 
et al., 2002) 
177 pencil 50 10 0.12 
This work 162 uniform 50 4 3.79 
HCL (Yan et al., 
2002) 
151 passive 50 8.2 4.8 
HCL (Polf and 
Newhauser, 
2005) 
160 passive 50 3 3.9 
This work 226 uniform 7.5 4 16.61 
LLUMC 
(Moyers et al., 
2008) 
250 passive 11.5 10 13.6 
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As shown in the table, Zheng et. al. (Zheng et al., 2012) conducted a study for the 
same uniform system used in this study at the ProCure Proton Therapy Center, 
Oklahoma, USA.  For a 78 MeV proton beam Zheng et. al. reported 0.35 mSv/Gy at 50 
cm off-axis to the primary beam with a 30 × 30 × 30 cm3 phantom centered at 
isocenter for a 4 cm SOBP. In our study, Hn/Dp for the same beam conditions, but at 
35.5 cm off-axis to primary beam, was found to be 0.49 mSv/Gy. Hn/Dp measured by 
Zheng et al. differed by 28% from our measured data. This could be due to the fact 
that detector distance in the current study was closer to the isocenter than that used 
in Zheng et al study. In addition, Zheng et. al. measured neutron dose equivalent 
using a SWENDI-II neutron detector, where the measurements technique of dose 
equivalent is different than that for CR-39 PNTD and this can enhance the difference 
in the measured Hn/Dp.   
 
In another study, Hecksel et. al. (Hecksel et al., 2010) reported 0.8 mSv/Gy for a 
uniform scanning system at 40 cm off-axis to the primary beam with 10 cm SOBP for 
a 151 MeV proton beam. This study was conducted at the Midwest Proton 
Radiotherapy Institute, USA (MPRI) using a SWENDII-II neutron detector. This 
result disagrees with our study by a factor of 4.7 for a 162 MeV proton beam. This 
disagreement could be due to the difference in dose equivalent measurement 
technique, difference in SOBP, and difference in energy between our study and that 
of Hecksel et. al.  
 
     
141 
 
For a 177 MeV proton beam, Schneider et. al. (Schneider et al., 2002) conducted a 
study using pencil beam scanning system at Paul Scherrer Institute (PSI) Proton 
Therapy Facility, Switzerland. The study was performed with the help of Bonner 
spheres, CR-39 PNTD and FLUKA Monte Carlo radiation transport code. At 50 cm 
off-axis to the primary beam, with 10 cm SOBP, the reported Hn/Dp using a Bonner 
sphere of 25 cm diameter was 0.12 mSV/Gy. At the similar location, the Hn/Dp from 
our study for a 162 MeV proton beam, disagreed by a factor of 32.5. It is important 
to note that pencil beam scanning systems do not use any beam shaping 
components (e.g. patient collimator) to conform the beam to the treatment volume. 
On the other hand, uniform scanning systems uses beam shaping components to 
conform the beam to the tumor and this might have caused a greater Hn/Dp in our 
study. 
 
 In a separate study at the Harvard Cyclotron Laboratory (HCL), Yan et al. (Yan et al., 
2002) reported 4.5 mSv/Gy at 50 cm off-axis to the primary beam, for a 160 MeV 
proton beam, 8.2 cm modulation width, and with a phantom at isocenter of 26 cm 
diameter and 24 cm length. This measurement was done for a passive scattering 
beam delivery system using a set of Bonner spheres of varying diameters (5.1 cm to 
45.7 cm). At a similar location, our measured value was 3.8 mSv/Gy for a 162 MeV 
proton beam. In another study, Polf and Newhauser (Polf and Newhauser, 2005) 
numerically simulated similar experimental conditions to those used by Yan et al. 
(Yan et al., 2002) using the MCNPX Monte Carlo radiation transport code. Polf et. al. 
reported a 3.9 mSv/Gy for a 160 MeV proton beam, 3 cm modulation width at 900 to 
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the beam axis and 50 cm from the isocenter. Overall, the studies conducted by Yan 
et. al. and Polf et. al. agree with our study within 15%, suggesting that the 
production of secondary neutrons in a passive scattering system is similar to that 
created in a uniform scanning system.  
 
For relatively higher energy (at 250 MeV), Moyers et. al. (Moyers et al., 2008) 
reported Hn/Dp at multiple off-axis locations for a passive scattering system installed 
at the Loma Linda University Medical Center, USA  (LLUMC). Five different 
approaches were employed in this study for the measurement of Hn/Dp for a 250 
MeV proton beam around the beam delivery system. One of the approach used CR-
39 PNTD, where the method to determine the dose equivalent from CR-39 PNTD 
was identical to the method used in this study. At 11.5 cm off-axis to the primary 
beam and 15 cm inside the phantom, the reported Hn/Dp was 13.6 mSv/Gy. For a 
similar location, at 7 cm off-axis and 10 cm inside the phantom, the measured Hn/Dp 
from this study is 16.6 mSv/Gy. The agreement between this study and the study 
carried by Moyers et. al. is within 18%. This result again suggests the neutron dose 
equivalent from a uniform scanning system is similar to that of a passive scattering 
system.     
 
The overall comparison indicates that the Hn/Dp due to secondary neutrons from a 
uniform scanning system is of a similar order of magnitude to that of passive 
scattering systems, but lower than that produced by pencil beam scanning systems. 
This study suggests that the available snout used in the uniform scanning system 
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may need to be improved if a reduction in Hn/Dp due to secondary neutrons is to be 
achieved.  
 
The statistical uncertainty in the FLUKA simulation was calculated to be around 
10%, though the fluence to dose equivalent conversion in the simulation could add 
as much as 30% uncertainty to the values of Hn/Dp (Schneider et al., 2002). On the 
other hand, the dose equivalent measurements in CR-39 PNTD are model 
independent, although the measurement process and detector calibration could still 
lead to up to 25% uncertainty in the measured results. Despite these uncertainties, 
the quantitative data on Hn/Dp at various distances from isocenter demonstrates the 
possible neutron exposure that a patient would receive from a common proton 
treatment facility that employs a uniform beam delivery system. In addition, this 
data can be used to find the organ equivalent dose, which can help in estimating the 
risks of secondary cancer for patients undergoing proton radiotherapy. Also, our 
study can improve the available radiation risk models which could ultimately help 
the clinicians to make informed decisions in future.     
 
This study did not incorporate the contribution of Hn/Dp from thermal and 
epithermal neutrons (<1 MeV), because CR-39 PNTD is insensitive to neutrons in 
that energy region. To incorporate the contribution of neutrons <1 MeV, a new 
experiment could be performed. For this purpose, a pair of 6LiF foils can be 
sandwiched between the CR-39 PNTDs, where one of the detectors is covered by a 
thermal neutron absorber (Gd) and the other is left uncovered. The design of the 
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experiment could be adapted from the work carried out by Benton et. al. (Benton et 
al., 2001), where the measurement was done to detect thermal and resonance 
neutrons during spaceflight. 6LiF has a high cross section for low energy neutrons 
and the absorption of low energy neutron leads to the 6 i(n,T)α reaction. The α and 
3T produced in the uncovered 6LiF will then create tracks to the CR-39 PNTD and 
these tracks are due to thermal neutrons. The covered foils, on the other hand, will 
see no thermal neutrons as they will be absorbed by gadolinium (Gd) absorber. The 
measurement of tracks due to covered and uncovered pair of 6LiF will be due to 
neutrons of < 1 MeV (as in this study).  
 
This study could not separate the contribution from external and internal neutrons 
using the current setup. For example, at 35.5 cm from beam isocenter, the 
experimentally measured Hn/Dp for a 162 MeV is 1.7 mSv/Gy and 2.3 mSv/Gy for 
solid-phantom and hollow-phantom configuration, respectively. This states that a 
higher Hn/Dp was observed in the configuration where secondary neutrons due to 
primary protons were supposed to be minimal. However, this suggests that the 
production of neutrons in the phantom by the primary proton beam is overwhelmed 
by the neutrons created in the beam delivery device. In the future, a Monte Carlo 
simulation can be done to separate the contribution of internal and external 
neutrons.  
   
In addition, this study did not include any range compensator which may lead to 
some differences in the actual neutron dose equivalent to tissue surrounding the 
     
145 
 
treatment volume in an actual patient treatment.  The whole study was conducted 
only for one particular setup of treatment parameters which might be different from 
an actual treatment scenario. In the future, experiments can be performed for 
varying patient specific parameters, e.g. various beam scanning areas, different 
snout size, and different SOBP can be performed for the better estimation of Hn/Dp. 
This can help in understanding the detailed distribution of neutron dose in proton 
radiotherapy. Finally, a detailed simulation of the beam delivery system can be done 
to improve the agreement between experiment and simulation. 
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